10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2013

Or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 1-11239

HCA Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware	27-3865930
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
One Park Plaza Nashville, Tennessee	37203
(Address of principal executive offices)	(Zip Code)

(615) 344-9551

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨ (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

Class of Common Stock	Outstanding at July 31, 2013
Voting common stock, $.01 par value	447,200,900 shares

HCA HOLDINGS, INC.

Form 10-Q

June 30, 2013

		Page of Form 10-Q
Part I.	Financial Information
Item 1.	Financial Statements (Unaudited):
	Condensed Consolidated Income Statements — for the quarters and six months ended June  30, 2013 and 2012	2
	Condensed Consolidated Comprehensive Income Statements — for the quarters and six months ended June 30, 2013 and 2012	3
	Condensed Consolidated Balance Sheets — June 30, 2013 and December 31, 2012	4
	Condensed Consolidated Statements of Cash Flows  — for the six months ended June 30, 2013 and 2012	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	29
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	47
Item 4.	Controls and Procedures	47
Part II.	Other Information
Item 1.	Legal Proceedings	47
Item 1A.	Risk Factors	49
Item 5.	Other Information	50
Item 6.	Exhibits	52
Signatures		53

1

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED INCOME STATEMENTS

FOR THE QUARTERS AND SIX MONTHS ENDED JUNE 30, 2013 AND 2012

Unaudited

(Dollars in millions, except per share amounts)

	Quarter						Six Months
	2013			2012			2013			2012
Revenues before provision for doubtful accounts	$	9,473		$	9,153		$	18,667		$	18,352
Provision for doubtful accounts		1,023			1,041			1,777			1,835
Revenues		8,450			8,112			16,890			16,517
Salaries and benefits		3,848			3,707			7,765			7,443
Supplies		1,470			1,422			2,949			2,841
Other operating expenses		1,507			1,493			3,030			2,986
Electronic health record incentive income		(52	)		(70	)		(91	)		(125	)
Equity in earnings of affiliates		(12	)		(9	)		(20	)		(20	)
Depreciation and amortization		425			420			849			837
Interest expense		462			448			934			890
Losses (gains) on sales of facilities		(4	)		2			12			3
Loss on retirement of debt		—			—			17			—
		7,644			7,413			15,445			14,855
Income before income taxes		806			699			1,445			1,662
Provision for income taxes		269			214			470			538
Net income		537			485			975			1,124
Net income attributable to noncontrolling interests		114			94			208			193
Net income attributable to HCA Holdings, Inc.	$	423		$	391		$	767		$	931
Per share data:
Basic earnings per share	$	0.95		$	0.89		$	1.72		$	2.12
Diluted earnings per share	$	0.91		$	0.85		$	1.66		$	2.03
Cash dividends declared per share	$	—		$	—		$	—		$	2.00
Shares used in earnings per share calculations (in thousands):
Basic		446,612			439,473			445,513			438,705
Diluted		463,184			458,621			462,782			458,467

See accompanying notes.

2

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS

FOR THE QUARTERS AND SIX MONTHS ENDED JUNE 30, 2013 AND 2012

Unaudited

(Dollars in millions)

	Quarter						Six Months
	2013			2012			2013			2012
Net income	$	537		$	485		$	975		$	1,124
Other comprehensive income (loss) before taxes:
Foreign currency translation		—			(22	)		(60	)		7
Unrealized (losses) gains on available-for-sale securities		(9	)		—			(8	)		5
Defined benefit plans		—			—			—			—
Pension costs included in salaries and benefits		8			7			15			14
		8			7			15			14
Change in fair value of derivative financial instruments		47			(77	)		40			(102	)
Interest costs included in interest expense		32			31			64			60
		79			(46	)		104			(42	)
Other comprehensive income (loss) before taxes		78			(61	)		51			(16	)
Income taxes (benefits) related to other comprehensive income items		29			(23	)		20			(7	)
Other comprehensive income (loss)		49			(38	)		31			(9	)
Comprehensive income		586			447			1,006			1,115
Comprehensive income attributable to noncontrolling interests		114			94			208			193
Comprehensive income attributable to HCA Holdings, Inc.	$	472		$	353		$	798		$	922

See accompanying notes.

3

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Unaudited

(Dollars in millions)

	June 30, 2013			December 31, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	462		$	705
Accounts receivable, less allowance for doubtful accounts of $4,965 and $4,846		4,915			4,672
Inventories		1,152			1,086
Deferred income taxes		401			385
Other		861			915
		7,791			7,763
Property and equipment, at cost		30,077			29,527
Accumulated depreciation		(16,848	)		(16,342	)
		13,229			13,185
Investments of insurance subsidiaries		405			515
Investments in and advances to affiliates		120			104
Goodwill and other intangible assets		5,534			5,539
Deferred loan costs		264			290
Other		591			679
	$	27,934		$	28,075
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	1,657		$	1,768
Accrued salaries		1,036			1,120
Other accrued expenses		1,871			1,849
Long-term debt due within one year		1,456			1,435
		6,020			6,172
Long-term debt		26,744			27,495
Professional liability risks		960			973
Income taxes and other liabilities		1,695			1,776
Stockholders’ deficit:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 447,066,900 shares in 2013 and 443,200,200 shares in 2012		4			4
Capital in excess of par value		1,792			1,753
Accumulated other comprehensive loss		(426	)		(457	)
Retained deficit		(10,193	)		(10,960	)
Stockholders’ deficit attributable to HCA Holdings, Inc.		(8,823	)		(9,660	)
Noncontrolling interests		1,338			1,319
		(7,485	)		(8,341	)
	$	27,934		$	28,075

See accompanying notes.

4

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2013 AND 2012

Unaudited

(Dollars in millions)

	2013			2012
Cash flows from operating activities:
Net income	$	975		$	1,124
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities		(2,335	)		(1,927	)
Provision for doubtful accounts		1,777			1,835
Depreciation and amortization		849			837
Income taxes		183			326
Losses on sales of facilities		12			3
Loss on retirement of debt		17			—
Amortization of deferred loan costs		28			29
Share-based compensation		51			23
Other		(3	)		7
Net cash provided by operating activities		1,554			2,257
Cash flows from investing activities:
Purchase of property and equipment		(896	)		(784	)
Acquisition of hospitals and health care entities		(23	)		(139	)
Disposition of hospitals and health care entities		31			6
Change in investments		102			35
Other		(4	)		(4	)
Net cash used in investing activities		(790	)		(886	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350
Net change in revolving credit facilities		(20	)		(820	)
Repayment of long-term debt		(768	)		(608	)
Distributions to noncontrolling interests		(196	)		(191	)
Payment of debt issuance costs		(5	)		(19	)
Distributions to stockholders		(10	)		(982	)
Income tax benefits		61			71
Other		(69	)		(27	)
Net cash used in financing activities		(1,007	)		(1,226	)
Change in cash and cash equivalents		(243	)		145
Cash and cash equivalents at beginning of period		705			373
Cash and cash equivalents at end of period	$	462		$	518
Interest payments	$	909		$	854
Income tax payments, net	$	226		$	141

See accompanying notes.

5

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Reporting Entity

On November 17, 2006, HCA Inc. was acquired by a private investor group, including affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners and HCA founder, Dr. Thomas F. Frist Jr. and by members of management and certain other investors. The transaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. As a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities Exchange Act of 1934.

During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock. Upon the completion of a secondary offering in February 2013, we no longer qualify as a “controlled company” under the applicable New York Stock Exchange (“NYSE”) listing standards and will be required to appoint a board of directors comprised of a majority of independent members within one year of such date. Our common stock is traded on the NYSE (symbol “HCA”).

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At June 30, 2013, these affiliates owned and operated 161 hospitals, 114 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $65 million and $59 million for the quarters ended June 30, 2013 and 2012, respectively, and $131 million and $112 million for the six months ended June 30, 2013 and 2012, respectively. Operating results for the quarter and the six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

6

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Basis of Presentation (continued)

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,976			23.4	%	$	1,989			24.5	%
Managed Medicare		804			9.5			729			9.0
Medicaid		365			4.3			380			4.7
Managed Medicaid		378			4.5			358			4.4
Managed care and other insurers		4,655			55.1			4,473			55.1
International (managed care and other insurers)		291			3.4			266			3.3
		8,469			100.2			8,195			101.0
Uninsured		693			8.2			739			9.1
Other		311			3.7			219			2.7
Revenues before provision for doubtful accounts		9,473			112.1			9,153			112.8
Provision for doubtful accounts		(1,023	)		(12.1	)		(1,041	)		(12.8	)
Revenues	$	8,450			100.0	%	$	8,112			100.0	%

	Six Months
	2013			Ratio			2012			Ratio
Medicare	$	4,114			24.4	%	$	4,302			26.0	%
Managed Medicare		1,647			9.8			1,479			9.0
Medicaid		697			4.1			810			4.9
Managed Medicaid		779			4.6			700			4.2
Managed care and other insurers		9,141			54.1			8,918			54.0
International (managed care and other insurers)		581			3.4			526			3.2
		16,959			100.4			16,735			101.3
Uninsured		1,092			6.5			1,181			7.2
Other		616			3.6			436			2.6
Revenues before provision for doubtful accounts		18,667			110.5			18,352			111.1
Provision for doubtful accounts		(1,777	)		(10.5	)		(1,835	)		(11.1	)
Revenues	$	16,890			100.0	%	$	16,517			100.0	%

The decline in Medicare revenues for the six months ended June 30, 2013 compared to the six months ended June 30, 2012 was primarily due to Medicare revenues for the six months ended June 30, 2012 being impacted by

7

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Basis of Presentation (continued)

two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the six months ended June 30, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

During the six months ended June 30, 2013 and 2012, we paid $23 million and $81 million, respectively, to acquire nonhospital health care entities. During the six months ended June 30, 2012, we paid $58 million, assumed liabilities of $33 million and recorded goodwill of $53 million related to the acquisition of a hospital facility in the American Group.

During the six months ended June 30, 2013, we received proceeds of $31 million and recognized net pretax losses of $12 million related to the sale of a hospital facility and other real estate investments. During the six months ended June 30, 2012, we received proceeds of $6 million and recognized net pretax losses of $3 million related to sales of real estate investments.

NOTE 3 — INCOME TAXES

During the six months ended June 30, 2013, we finalized settlements with the IRS resolving all outstanding issues for HCA Inc.’s 2007, 2008 and 2009 tax years. We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2010 and 2011 federal income tax returns in 2013.

Our liability for unrecognized tax benefits was $408 million, including accrued interest of $18 million, as of June 30, 2013 ($426 million and $14 million, respectively, as of December 31, 2012). Unrecognized tax benefits of $134 million ($125 million as of December 31, 2012) would affect the effective rate, if recognized. The provision for income taxes reflects $3 million ($2 million, net of tax) of interest expense and $18 million ($11 million, net of tax) of reductions in interest expense related to taxing authority examinations for the quarters ended June 30, 2013 and 2012, respectively, and $15 million and $21 million ($9 million and $13 million, respectively, net of tax) of reductions in interest expense related to taxing authority examinations for the six months ended June 30, 2013 and 2012, respectively.

Depending on the completion of examinations by federal, state or international taxing authorities, the resolution of any tax disputes, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

NOTE 4 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.

8

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 4 — EARNINGS PER SHARE (continued)

The following table sets forth the computation of basic and diluted earnings per share for the quarters and six months ended June 30, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	Quarter				Six Months
	2013		2012		2013		2012
Net income attributable to HCA Holdings, Inc.	$	423	$	391	$	767	$	931
Weighted average common shares outstanding		446,612		439,473		445,513		438,705
Effect of dilutive incremental shares		16,572		19,148		17,269		19,762
Shares used for diluted earnings per share		463,184		458,621		462,782		458,467
Earnings per share:
Basic earnings per share	$	0.95	$	0.89	$	1.72	$	2.12
Diluted earnings per share	$	0.91	$	0.85	$	1.66	$	2.03

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES

A summary of our insurance subsidiaries’ investments at June 30, 2013 and December 31, 2012 follows (dollars in millions):

	June 30, 2013
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	384	$	12	$	(2	)	$	394
Auction rate securities		47		—		(2	)		45
Asset-backed securities		12		—		—			12
Money market funds		17		—		—			17
		460		12		(4	)		468
Equity securities		2		1		—			3
	$	462	$	13	$	(4	)		471
Amounts classified as current assets									(66	)
Investment carrying value								$	405

9

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES (continued)

	December 31, 2012
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—		$	418
Auction rate securities		74		—		(6	)		68
Asset-backed securities		14		—		—			14
Money market funds		67		—		—			67
		550		23		(6	)		567
Equity securities		2		1		—			3
	$	552	$	24	$	(6	)		570
Amounts classified as current assets									(55	)
Investment carrying value								$	515

At June 30, 2013 and December 31, 2012, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. At June 30, 2013 and December 31, 2012, $1 million and $9 million, respectively, of our money market fund investments were subject to restrictions included in insurance bond collateralization and assumed reinsurance contracts.

Scheduled maturities of investments in debt securities at June 30, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	31	$	31
Due after one year through five years		174		180
Due after five years through ten years		103		106
Due after ten years		93		94
		401		411
Auction rate securities		47		45
Asset-backed securities		12		12
	$	460	$	468

The average expected maturity of the investments in debt securities at June 30, 2013 was 4.4 years, compared to the average scheduled maturity of 7.7 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to the scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. At June 30, 2013, the average expected maturities for our auction rate and asset-backed securities were 3.9 years and 3.7 years, respectively, compared to average scheduled maturities of 21.5 years and 23.5 years, respectively.

10

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS

Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at June 30, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(7	)
Pay-fixed interest rate swaps		3,000		December 2016		(273	)
Pay-fixed interest rate swaps		1,000		December 2017		(45	)

During the next 12 months, we estimate $125 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at June 30, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(17	)

Derivatives — Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the six months ended June 30, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Gain Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	25		Interest expense	$	64

11

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS (continued)

Derivatives — Results of Operations (continued)

Derivatives Not Designated as Hedging Instruments	Location of Loss Recognized in Operations on Derivatives		Amount of Loss Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	4

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of June 30, 2013, we have not been required to post any collateral related to these agreements. If we had breached these provisions at June 30, 2013, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $358 million.

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The transaction price is initially used as the best estimate of fair value.

12

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Cash Traded Investments (continued)

Our wholly-owned insurance subsidiaries had investments in tax-exempt auction rate securities (“ARS”), which are backed by student loans substantially guaranteed by the federal government, of $45 million ($47 million par value) at June 30, 2013. We do not currently intend to attempt to sell the ARS as the liquidity needs of our insurance subsidiaries are expected to be met by other investments in their investment portfolios. During 2012 and the six months ended June 30, 2013, certain issuers and their broker/dealers redeemed or repurchased $65 million and $27 million, respectively, of our ARS at par value. The valuation of these securities involved management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived a fair market value compared to tax-equivalent yields of other student loan backed variable rate securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at June 30, 2013 and December 31, 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

13

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of June 30, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	June 30, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	394		$	—		$	394		$	—
Auction rate securities		45			—			—			45
Asset-backed securities		12			—			12			—
Money market funds		17			17			—			—
		468			17			406			45
Equity securities		3			2			—			1
Investments of insurance subsidiaries		471			19			406			46
Less amounts classified as current assets		(66	)		(17	)		(49	)		—
	$	405		$	2		$	357		$	46
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	17		$	—		$	17		$	—
Interest rate swaps (Income taxes and other liabilities)		325			—			325			—

14

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the six months ended June 30, 2013 (dollars in millions):

Asset balances at December 31, 2012	$	70
Unrealized gains included in other comprehensive income		3
Settlements		(27	)
Asset balances at June 30, 2013	$	46

The estimated fair value of our long-term debt was $28.061 billion and $30.781 billion at June 30, 2013 and December 31, 2012, respectively, compared to carrying amounts aggregating $28.200 billion and $28.930 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

15

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 8 — LONG-TERM DEBT

A summary of long-term debt at June 30, 2013 and December 31, 2012, including related interest rates at June 30, 2013, follows (dollars in millions):

	June 30, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	1,450	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.1%)		5,939		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,691		9,688
Other senior secured debt (effective interest rate of 7.0%)		426		423
First lien debt		17,506		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,694		11,194
Total debt (average life of 6.7 years, rates averaging 6.4%)		28,200		28,930
Less amounts due within one year		1,456		1,435
	$	26,744	$	27,495

2013 Activity

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 ⁷/₈% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

16

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS (continued)

Government Investigations, Claims and Litigation (continued)

As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named

17

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS (continued)

Securities Class Action Litigation (continued)

officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action has also been stayed pending developments in the shareholder class actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling. The accounting for HCA’s capital expenditures and charity and uncompensated care is ongoing and will likely not be concluded before the end of 2013. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters final judgment.

NOTE 10 — CAPITAL STRUCTURE

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		Par Value
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			767			208			975
Other comprehensive income		—		—		—			31			—			—			31
Distributions		—		—		—			—			—			(196	)		(196	)
Share-based benefit plans		3,867		—		41			—			—			—			41
Other		—		—		(2	)		—			—			7			5
Balances at June 30, 2013		447,067	$	4	$	1,792		$	(426	)	$	(10,193	)	$	1,338		$	(7,485	)

18

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 10 — CAPITAL STRUCTURE (continued)

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities			Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11		$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(5	)		—			—			—			(5	)
Foreign currency translation adjustments, net of $21 income tax benefit		—			(39	)		—			—			(39	)
Change in fair value of derivative instruments, net of $15 of income taxes		—			—			—			25			25
Expense reclassified into operations from other comprehensive income, net of $6 and $23, respectively, income tax benefits		—			—			9			41			50
Balances at June 30, 2013	$	6		$	(40	)	$	(187	)	$	(205	)	$	(426	)

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The National Group includes 77 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group includes 78 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.

19

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION (continued)

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses (gains) on sales of facilities, loss on retirement of debt, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter						Six Months
	2013			2012			2013			2012
Revenues:
National Group	$	3,964		$	3,806		$	7,945		$	7,798
American Group		4,065			3,966			8,099			8,051
Corporate and other		421			340			846			668
	$	8,450		$	8,112		$	16,890		$	16,517
Equity in earnings of affiliates:
National Group	$	(3	)	$	(3	)	$	(5	)	$	(7	)
American Group		(7	)		(7	)		(13	)		(14	)
Corporate and other		(2	)		1			(2	)		1
	$	(12	)	$	(9	)	$	(20	)	$	(20	)
Adjusted segment EBITDA:
National Group	$	831		$	789		$	1,635		$	1,710
American Group		916			841			1,744			1,814
Corporate and other		(58	)		(61	)		(122	)		(132	)
	$	1,689		$	1,569		$	3,257		$	3,392
Depreciation and amortization:
National Group	$	177		$	176		$	351		$	349
American Group		202			202			404			405
Corporate and other		46			42			94			83
	$	425		$	420		$	849		$	837
Adjusted segment EBITDA	$	1,689		$	1,569		$	3,257		$	3,392
Depreciation and amortization		425			420			849			837
Interest expense		462			448			934			890
Losses (gains) on sales of facilities		(4	)		2			12			3
Loss on retirement of debt		—			—			17			—
Income before income taxes	$	806		$	699		$	1,445		$	1,662

20

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7  ³/₄% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, wholly-owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).

Our summarized condensed consolidating comprehensive income statements for the quarters and six months ended June 30, 2013 and 2012, condensed consolidating balance sheets at June 30, 2013 and December 31, 2012 and condensed consolidating statements of cash flows for the six months ended June 30, 2013 and 2012, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	5,012		$	4,461		$	—		$	9,473
Provision for doubtful accounts		—			—			608			415			—			1,023
Revenues		—			—			4,404			4,046			—			8,450
Salaries and benefits		—			—			2,058			1,790			—			3,848
Supplies		—			—			776			694			—			1,470
Other operating expenses		1			—			757			749			—			1,507
Electronic health record incentive income		—			—			(33	)		(19	)		—			(52	)
Equity in earnings of affiliates		(504	)		—			(1	)		(11	)		504			(12	)
Depreciation and amortization		—			—			211			214			—			425
Interest expense		51			544			(109	)		(24	)		—			462
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Management fees		—			—			(181	)		181			—			—
		(452	)		544			3,481			3,567			504			7,644
Income (loss) before income taxes		452			(544	)		923			479			(504	)		806
Provision (benefit) for income taxes		(20	)		(213	)		354			148			—			269
Net income (loss)		472			(331	)		569			331			(504	)		537
Net income attributable to noncontrolling interests		—			—			16			98			—			114
Net income (loss) attributable to HCA Holdings, Inc.	$	472		$	(331	)	$	553		$	233		$	(504	)	$	423
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	472		$	(283	)	$	558		$	229		$	(504	)	$	472

21

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,753		$	4,400		$	—		$	9,153
Provision for doubtful accounts		—			—			558			483			—			1,041
Revenues		—			—			4,195			3,917			—			8,112
Salaries and benefits		—			—			1,951			1,756			—			3,707
Supplies		—			—			738			684			—			1,422
Other operating expenses		—			—			751			742			—			1,493
Electronic health record incentive income		—			—			(48	)		(22	)		—			(70	)
Equity in earnings of affiliates		(409	)		—			(1	)		(8	)		409			(9	)
Depreciation and amortization		—			—			209			211			—			420
Interest expense		30			529			(85	)		(26	)		—			448
Losses on sales of facilities		—			—			2			—			—			2
Management fees		—			—			(168	)		168			—			—
		(379	)		529			3,349			3,505			409			7,413
Income (loss) before income taxes		379			(529	)		846			412			(409	)		699
Provision (benefit) for income taxes		(12	)		(189	)		297			118			—			214
Net income (loss)		391			(340	)		549			294			(409	)		485
Net income attributable to noncontrolling interests		—			—			16			78			—			94
Net income (loss) attributable to HCA Holdings, Inc.	$	391		$	(340	)	$	533		$	216		$	(409	)	$	391
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	391		$	(369	)	$	538		$	202		$	(409	)	$	353

22

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	9,884		$	8,783		$	—		$	18,667
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Revenues		—			—			8,833			8,057			—			16,890
Salaries and benefits		—			—			4,185			3,580			—			7,765
Supplies		—			—			1,567			1,382			—			2,949
Other operating expenses		2			—			1,489			1,539			—			3,030
Electronic health record incentive income		—			—			(62	)		(29	)		—			(91	)
Equity in earnings of affiliates		(860	)		—			(2	)		(18	)		860			(20	)
Depreciation and amortization		—			—			420			429			—			849
Interest expense		97			1,102			(215	)		(50	)		—			934
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(364	)		364			—			—
		(761	)		1,119			7,037			7,190			860			15,445
Income (loss) before income taxes		761			(1,119	)		1,796			867			(860	)		1,445
Provision (benefit) for income taxes		(37	)		(425	)		671			261			—			470
Net income (loss)		798			(694	)		1,125			606			(860	)		975
Net income attributable to noncontrolling interests		—			—			29			179			—			208
Net income (loss) attributable to HCA Holdings, Inc.	$	798		$	(694	)	$	1,096		$	427		$	(860	)	$	767
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	798		$	(630	)	$	1,105		$	385		$	(860	)	$	798

23

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	9,656		$	8,696		$	—		$	18,352
Provision for doubtful accounts		—			—			1,021			814			—			1,835
Revenues		—			—			8,635			7,882			—			16,517
Salaries and benefits		—			—			3,933			3,510			—			7,443
Supplies		—			—			1,491			1,350			—			2,841
Other operating expenses		—			4			1,480			1,502			—			2,986
Electronic health record incentive income		—			—			(89	)		(36	)		—			(125	)
Equity in earnings of affiliates		(969	)		—			(3	)		(17	)		969			(20	)
Depreciation and amortization		—			—			409			428			—			837
Interest expense		60			1,058			(176	)		(52	)		—			890
Losses on sales of facilities		—			—			3			—			—			3
Management fees		—			—			(328	)		328			—			—
		(909	)		1,062			6,720			7,013			969			14,855
Income (loss) before income taxes		909			(1,062	)		1,915			869			(969	)		1,662
Provision (benefit) for income taxes		(22	)		(389	)		689			260			—			538
Net income (loss)		931			(673	)		1,226			609			(969	)		1,124
Net income attributable to noncontrolling interests		—			—			33			160			—			193
Net income (loss) attributable to HCA Holdings, Inc.	$	931		$	(673	)	$	1,193		$	449		$	(969	)	$	931
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	931		$	(698	)	$	1,202		$	456		$	(969	)	$	922

24

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	152		$	310	$	—		$	462
Accounts receivable, net		—			—			2,492			2,423		—			4,915
Inventories		—			—			683			469		—			1,152
Deferred income taxes		401			—			—			—		—			401
Other		—			—			309			552		—			861
		401			—			3,636			3,754		—			7,791
Property and equipment, net		—			—			7,432			5,797		—			13,229
Investments of insurance subsidiaries		—			—			—			405		—			405
Investments in and advances to affiliates		19,341			—			15			105		(19,341	)		120
Goodwill and other intangible assets		—			—			1,695			3,839		—			5,534
Deferred loan costs		31			233			—			—		—			264
Other		362			—			26			203		—			591
	$	20,135		$	233		$	12,804		$	14,103	$	(19,341	)	$	27,934
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,090		$	567	$	—		$	1,657
Accrued salaries		—			—			601			435		—			1,036
Other accrued expenses		261			375			460			775		—			1,871
Long-term debt due within one year		—			1,381			43			32		—			1,456
		261			1,756			2,194			1,809		—			6,020
Long-term debt		2,525			23,555			174			490		—			26,744
Intercompany balances		25,729			(10,782	)		(18,290	)		3,343		—			—
Professional liability risks		—			—			—			960		—			960
Income taxes and other liabilities		443			342			674			236		—			1,695
		28,958			14,871			(15,248	)		6,838		—			35,419
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,823	)		(14,638	)		27,952			6,027		(19,341	)		(8,823	)
Noncontrolling interests		—			—			100			1,238		—			1,338
		(8,823	)		(14,638	)		28,052			7,265		(19,341	)		(7,485	)
	$	20,135		$	233		$	12,804		$	14,103	$	(19,341	)	$	27,934

25

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

26

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	798		$	(694	)	$	1,125		$	606		$	(860	)	$	975
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		41			(18	)		(1,217	)		(1,141	)		—			(2,335	)
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Depreciation and amortization		—			—			420			429			—			849
Income taxes		183			—			—			—			—			183
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		2			26			—			—			—			28
Share-based compensation		51			—			—			—			—			51
Equity in earnings of affiliates		(860	)		—			—			—			860			—
Other		—			4			—			(7	)		—			(3	)
Net cash provided by (used in) operating activities		215			(665	)		1,398			606			—			1,554
Cash flows from investing activities:
Purchase of property and equipment		—			—			(434	)		(462	)		—			(896	)
Acquisition of hospitals and health care entities		—			—			—			(23	)		—			(23	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			5			97			—			102
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(413	)		(377	)		—			(790	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			(20	)		—			—			—			(20	)
Repayment of long-term debt		—			(726	)		(22	)		(20	)		—			(768	)
Distributions to noncontrolling interests		—			—			(29	)		(167	)		—			(196	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(216	)		1,416			(1,165	)		(35	)		—			—
Income tax benefits		61			—			—			—			—			61
Other		(72	)		—			—			3			—			(69	)
Net cash (used in) provided by financing activities		(237	)		665			(1,216	)		(219	)		—			(1,007	)
Change in cash and cash equivalents		(22	)		—			(231	)		10			—			(243	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	152		$	310		$	—		$	462

27

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	931		$	(673	)	$	1,226		$	609		$	(969	)	$	1,124
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		—			12			(995	)		(944	)		—			(1,927	)
Provision for doubtful accounts		—			—			1,021			814			—			1,835
Depreciation and amortization		—			—			409			428			—			837
Income taxes		326			—			—			—			—			326
Losses on sales of facilities		—			—			3			—			—			3
Amortization of deferred loan costs		1			28			—			—			—			29
Share-based compensation		23			—			—			—			—			23
Equity in earnings of affiliates		(969	)		—			—			—			969			—
Other		—			8			(1	)		—			—			7
Net cash provided by (used in) operating activities		312			(625	)		1,663			907			—			2,257
Cash flows from investing activities:
Purchase of property and equipment		—			—			(408	)		(376	)		—			(784	)
Acquisition of hospitals and health care entities		—			—			(72	)		(67	)		—			(139	)
Disposition of hospitals and health care entities		—			—			1			5			—			6
Change in investments		—			—			(8	)		43			—			35
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(488	)		(398	)		—			(886	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(820	)		—			—			—			(820	)
Repayment of long-term debt		—			(545	)		(16	)		(47	)		—			(608	)
Distributions to noncontrolling interests		—			—			(36	)		(155	)		—			(191	)
Payment of debt issuance costs		—			(19	)		—			—			—			(19	)
Distributions to stockholders		(982	)		—			—			—			—			(982	)
Changes in intercompany balances with affiliates, net		628			659			(1,115	)		(172	)		—			—
Income tax benefits		71			—			—			—			—			71
Other		(29	)		—			—			2			—			(27	)
Net cash (used in) provided by financing activities		(312	)		625			(1,167	)		(372	)		—			(1,226	)
Change in cash and cash equivalents		—			—			8			137			—			145
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	123		$	395		$	—		$	518

28

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This quarterly report on Form 10-Q includes certain disclosures which contain “forward-looking statements.” Forward-looking statements include statements regarding estimated electronic health record (“EHR”) incentive income and related EHR operating expenses, expected capital expenditures, expected net claim payments and all other statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) the effects related to the implementation of the Budget Control Act of 2011 (the “BCA”) and the potential for future deficit reduction legislation that may alter BCA-mandated spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (4) increases in the amount and risk of collectibility of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in the Medicare, Medicaid and other state programs, including Medicaid upper payment limit (“UPL”) programs or Waiver Programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under managed care agreements, the ability to enter into and renew managed care provider agreements on acceptable terms and the impact of consumer driven health plans and physician utilization trends and practices, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) future divestitures which may result in charges and possible impairments of long-lived assets, (16) changes in business strategy or development plans, (17) delays in receiving payments for services provided, (18) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (19) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (20) our ongoing ability to demonstrate meaningful use of certified EHR technology and recognize income for the related Medicare or Medicaid incentive payments, and (21) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2012 and our other filings with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ from those expressed in any forward-looking statements made by or on behalf of HCA. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report, which forward-looking statements reflect management’s views only as of the date of this report. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.

Health Care Reform

The Health Reform Law changes how health care services are covered, delivered and reimbursed through expanded coverage of uninsured individuals, reduced growth in Medicare program spending, reductions

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Health Care Reform (continued)

in Medicare and Medicaid Disproportionate Share Hospital (“DSH”) payments, and the establishment of programs in which reimbursement is tied to quality and integration. In addition, the Health Reform Law reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement. The provisions of the Health Reform Law that seek to decrease the number of uninsured individuals mostly will become effective January 1, 2014. However, the employer mandate, which requires firms with 50 or more full-time employees to offer health insurance or pay fines, will be delayed until January 1, 2015. In addition, it is unclear how many states will decline to implement the Medicaid expansion provisions of the law. We are unable to predict with any reasonable certainty the likely impact of the Health Reform Law on our business model, financial condition or result of operations due to the law’s complexity, lack of implementing regulations or interpretive guidance, gradual and partially delayed implementation, court challenges and possible amendment, repeal or further implementation delays, as well as our inability to foresee how individuals, states and businesses will respond to the choices afforded them by the law.

Second Quarter 2013 Operations Summary

Revenues increased to $8.450 billion in the second quarter of 2013 from $8.112 billion in the second quarter of 2012. Net income attributable to HCA Holdings, Inc. totaled $423 million, or $0.91 per diluted share, for the quarter ended June 30, 2013, compared to $391 million, or $0.85 per diluted share, for the quarter ended June 30, 2012. Shares used for diluted earnings per share were 463.2 million shares for the quarter ended June 30, 2013 and 458.6 million shares for the quarter ended June 30, 2012.

Revenues increased 4.2% on a consolidated basis and increased 4.0% on a same facility basis for the quarter ended June 30, 2013, compared to the quarter ended June 30, 2012. The increase in consolidated revenues can be attributed to the combined impact of a 3.0% increase in revenue per equivalent admission and a 1.1% increase in equivalent admissions. The same facility revenues increase resulted from the combined impact of a 2.9% increase in same facility revenue per equivalent admission and a 1.1% increase in same facility equivalent admissions.

During the quarter ended June 30, 2013, consolidated admissions and same facility admissions increased 1.1% and 1.3%, respectively, compared to the quarter ended June 30, 2012. Inpatient surgeries declined 0.2% on a consolidated basis and increased 0.2% on a same facility basis during the quarter ended June 30, 2013, compared to the quarter ended June 30, 2012. Outpatient surgeries increased 1.1% on a consolidated basis and remained flat on a same facility basis during the quarter ended June 30, 2013, compared to the quarter ended June 30, 2012. Emergency department visits increased 0.7% on a consolidated basis and 0.8% on a same facility basis during the quarter ended June 30, 2013, compared to the quarter ended June 30, 2012.

For the quarter ended June 30, 2013, the provision for doubtful accounts declined $18 million, compared to the quarter ended June 30, 2012. The self-pay revenue deductions for charity care and uninsured discounts increased $64 million and $398 million, respectively, during the second quarter of 2013, compared to the second quarter of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, provision for doubtful accounts, uninsured discounts and charity care, was 31.2% for the second quarter of 2013, compared to 29.5% for the second quarter of 2012. Same facility uninsured admissions increased 6.3% and same facility uninsured emergency room visits increased 1.2% for the quarter ended June 30, 2013, compared to the quarter ended June 30, 2012.

Interest expense increased $14 million to $462 million for the quarter ended June 30, 2013 from $448 million for the quarter ended June 30, 2012. The increase in interest expense was due to an increase in the average debt balance.

30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Second Quarter 2013 Operations Summary (continued)

Cash flows from operating activities declined $646 million from $1.460 billion for the second quarter of 2012 to $814 million for the second quarter of 2013. The decline is primarily related to the combined impact of unfavorable changes in working capital items of $516 million and an increase of $193 million in income taxes.

Results of Operations

Revenue/Volume Trends

Our revenues depend upon inpatient occupancy levels, the ancillary services and therapy programs ordered by physicians and provided to patients, the volume of outpatient procedures and the charge and negotiated payment rates for such services. Gross charges typically do not reflect what our facilities are actually paid. Our facilities have entered into agreements with third-party payers, including government programs and managed care health plans, under which the facilities are paid based upon the cost of providing services, predetermined rates per diagnosis, fixed per diem rates or discounts from gross charges. We do not pursue collection of amounts related to patients who meet our guidelines to qualify for charity care; therefore, they are not reported in revenues. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. After the discounts are applied, we are still unable to collect a significant portion of uninsured patients’ accounts, and we record significant provisions for doubtful accounts (based upon our historical collection experience) related to uninsured patients in the period the services are provided.

Revenues increased 4.2% from $8.112 billion in the second quarter of 2012 to $8.450 billion in the second quarter of 2013. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from our third-party payers, the uninsured and other revenues for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following tables (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,976			23.4	%	$	1,989			24.5	%
Managed Medicare		804			9.5			729			9.0
Medicaid		365			4.3			380			4.7
Managed Medicaid		378			4.5			358			4.4
Managed care and other insurers		4,655			55.1			4,473			55.1
International (managed care and other insurers)		291			3.4			266			3.3
		8,469			100.2			8,195			101.0
Uninsured		693			8.2			739			9.1
Other		311			3.7			219			2.7
Revenues before provision for doubtful accounts		9,473			112.1			9,153			112.8
Provision for doubtful accounts		(1,023	)		(12.1	)		(1,041	)		(12.8	)
Revenues	$	8,450			100.0	%	$	8,112			100.0	%

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

	Six Months
	2013			Ratio			2012			Ratio
Medicare	$	4,114			24.4	%	$	4,302			26.0	%
Managed Medicare		1,647			9.8			1,479			9.0
Medicaid		697			4.1			810			4.9
Managed Medicaid		779			4.6			700			4.2
Managed care and other insurers		9,141			54.1			8,918			54.0
International (managed care and other insurers)		581			3.4			526			3.2
		16,959			100.4			16,735			101.3
Uninsured		1,092			6.5			1,181			7.2
Other		616			3.6			436			2.6
Revenues before provision for doubtful accounts		18,667			110.5			18,352			111.1
Provision for doubtful accounts		(1,777	)		(10.5	)		(1,835	)		(11.1	)
Revenues	$	16,890			100.0	%	$	16,517			100.0	%

The decline in Medicare revenues for the six months ended June 30, 2013 compared to the six months ended June 30, 2012 was primarily due to Medicare revenues for the six months ended June 30, 2012 being impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the six months ended June 30, 2012.

Consolidated and same facility revenue per equivalent admission increased 3.0% and 2.9%, respectively, in the second quarter of 2013, compared to the second quarter of 2012. Consolidated and same facility equivalent admissions each increased 1.1% in the second quarter of 2013, compared to the second quarter of 2012. Consolidated and same facility admissions increased 1.1% and 1.3%, respectively, in the second quarter of 2013, compared to the second quarter of 2012. Consolidated and same facility outpatient surgeries increased 1.1% and remained flat, respectively, in the second quarter of 2013, compared to the second quarter of 2012. Consolidated and same facility inpatient surgeries declined 0.2% and increased 0.2%, respectively, in the second quarter of 2013, compared to the second quarter of 2012. Consolidated and same facility emergency department visits increased 0.7% and 0.8%, respectively, in the second quarter of 2013, compared to the second quarter of 2012.

To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view the direct uninsured revenue deductions and provision for doubtful accounts in combination, rather than each separately. At June 30, 2013, our allowance for doubtful accounts represented approximately 93% of the $5.356 billion total patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured portion of our accounts receivable. A summary of these adjustments to revenues amounts, related to uninsured accounts, for the quarters and six months ended June 30, 2013 and 2012 follows (dollars in millions):

	Quarter										Six Months
	2013		Ratio			2012		Ratio			2013		Ratio			2012		Ratio
Charity care	$	797		21	%	$	733		21	%	$	1,702		23	%	$	1,531		23	%
Uninsured discounts		2,018		52			1,620		48			3,968		53			3,259		49
Provision for doubtful accounts		1,023		27			1,041		31			1,777		24			1,835		28
Totals	$	3,838		100	%	$	3,394		100	%	$	7,447		100	%	$	6,625		100	%

32

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

Same facility uninsured admissions increased by 2,084 admissions, or 6.3%, in the second quarter of 2013, compared to the second quarter of 2012. Same facility uninsured admissions increased by 1,688 admissions, or 5.4%, in the first quarter of 2013, compared to the first quarter of 2012. Same facility uninsured admissions in 2012, compared to 2011, increased 11.0% in the fourth quarter of 2012, increased 7.3% in the third quarter of 2012, increased 8.9% in the second quarter of 2012 and increased 11.6% in the first quarter of 2012.

The approximate percentages of our admissions related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters and six months ended June 30, 2013 and 2012 are set forth in the following table.

	Quarter						Six Months
	2013			2012			2013			2012
Medicare		32	%		33	%		33	%		34	%
Managed Medicare		13			12			13			12
Medicaid		8			8			8			8
Managed Medicaid		9			8			9			8
Managed care and other insurers		30			31			29			31
Uninsured		8			8			8			7
		100	%		100	%		100	%		100	%

The approximate percentages of our inpatient revenues, before provision for doubtful accounts, related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters and six months ended June 30, 2013 and 2012 are set forth in the following table.

	Quarter						Six Months
	2013			2012			2013			2012
Medicare		29	%		29	%		31	%		31	%
Managed Medicare		10			10			11			10
Medicaid		6			6			5			6
Managed Medicaid		4			4			4			4
Managed care and other insurers		46			45			46			45
Uninsured		5			6			3			4
		100	%		100	%		100	%		100	%

At June 30, 2013, we had 74 hospitals in the states of Texas and Florida. During the second quarter of 2013, 55% of our admissions and 46% of our revenues were generated by these hospitals. Uninsured admissions in Texas and Florida represented 63% of our uninsured admissions during the second quarter of 2013.

We receive a significant portion of our revenues from government health programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. We provide indigent care services in several communities in the state of Texas, in affiliation with other hospitals. The state of Texas has been involved in efforts to increase the indigent care provided by private hospitals. As a result of additional indigent care being provided by private hospitals, public hospital districts or counties in Texas have available funds that were previously devoted to indigent care. The public hospital districts or counties are under no contractual or legal obligation to provide such indigent care. The public hospital districts or counties have elected

33

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

to transfer some portion of these available funds to the state’s Medicaid program. Such action is at the sole discretion of the public hospital districts or counties. It is anticipated that these contributions to the state will be matched with federal Medicaid funds. The state then may make supplemental payments to hospitals in the state for Medicaid services rendered. Hospitals receiving Medicaid supplemental payments may include those that are providing additional indigent care services. Our Texas Medicaid revenues included $72 million and $112 million during the second quarters of 2013 and 2012, respectively, and $151 million and $240 million during the first six months of 2013 and 2012, respectively, of Medicaid supplemental payments. In addition, we receive supplemental payments in several other states. We are aware these supplemental payment programs are currently being reviewed by certain state agencies and some states have made waiver requests to the Centers for Medicare and Medicaid Services (“CMS”) to replace their existing supplemental payment programs. It is possible these reviews and waiver requests will result in the restructuring of such supplemental payment programs and could result in the payment programs being reduced or eliminated. In 2011, CMS approved a Medicaid waiver that allows Texas to continue receiving supplemental Medicaid reimbursement while expanding its Medicaid managed care program, thus Texas is operating pursuant to a Waiver Program. However, we cannot predict whether the Texas private supplemental Medicaid reimbursement program will continue or guarantee that revenues recognized for the program will not decline. Because deliberations about these programs are ongoing, we are unable to estimate the financial impact the program structure modifications, if any, may have on our results of operations.

Electronic Health Record Incentive Payments

The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments for eligible hospitals and professionals that adopt and meaningfully use certified EHR technology. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

We recognized $52 million and $70 million of electronic health record incentive income, primarily related to Medicare, during the second quarters of 2013 and 2012, respectively. We recognized $91 million and $125 million of electronic health record incentive income, primarily related to Medicare incentives, during the first six months of 2013 and 2012, respectively. At June 30, 2013, we have $27 million of deferred EHR incentive income, which represents incentive payments received for which EHR incentive income has not been recognized.

We have incurred and will continue to incur both capital costs and operating expenses in order to implement our certified EHR technology and meet meaningful use requirements. These expenses are ongoing and are projected to continue over all stages of implementation of meaningful use. The timing of recognizing the expenses may not correlate with the receipt of the incentive payments and the recognition of revenues. We incurred $33 million and $20 million during the second quarters of 2013 and 2012, respectively, and $59 million and $37 million during the first six months of 2013 and 2012, respectively, of operating expenses to implement our certified EHR technology and meet meaningful use.

For 2013, we estimate EHR incentive income will be recognized in the range of $200 million to $225 million and that related EHR operating expenses will be in the range of $120 million to $140 million. Actual incentive payments and EHR operating expenses could vary from these estimates due to certain factors such as availability of federal funding for both Medicare and Medicaid incentive payments and our ability to continue to demonstrate meaningful use of certified EHR technology. The failure of our ability to continue to demonstrate meaningful use of EHR technology could have a material, adverse effect on our results of operations.

34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Operating Results Summary

The following is a comparative summary of results from operations for the quarters and six months ended June 30, 2013 and 2012 (dollars in millions):

	Quarter
	2013						2012
	Amount			Ratio			Amount			Ratio
Revenues before provision for doubtful accounts	$	9,473					$	9,153
Provision for doubtful accounts		1,023						1,041
Revenues		8,450			100.0			8,112			100.0
Salaries and benefits		3,848			45.5			3,707			45.7
Supplies		1,470			17.4			1,422			17.5
Other operating expenses		1,507			17.8			1,493			18.5
Electronic health record incentive income		(52	)		(0.6	)		(70	)		(0.9	)
Equity in earnings of affiliates		(12	)		(0.1	)		(9	)		(0.1	)
Depreciation and amortization		425			5.1			420			5.2
Interest expense		462			5.5			448			5.5
Losses (gains) on sales of facilities		(4	)		(0.1	)		2			—
		7,644			90.5			7,413			91.4
Income before income taxes		806			9.5			699			8.6
Provision for income taxes		269			3.2			214			2.6
Net income		537			6.3			485			6.0
Net income attributable to noncontrolling interests		114			1.3			94			1.2
Net income attributable to HCA Holdings, Inc.	$	423			5.0		$	391			4.8
% changes from prior year:
Revenues		4.2	%					11.9	%
Income before income taxes		15.1						49.6
Net income attributable to HCA Holdings, Inc.		8.1						70.3
Admissions(a)		1.1						7.7
Equivalent admissions(b)		1.1						9.7
Revenue per equivalent admission		3.0						2.0
Same facility % changes from prior year(c):
Revenues		4.0						3.8
Admissions(a)		1.3						2.5
Equivalent admissions(b)		1.1						3.9
Revenue per equivalent admission		2.9						(0.1	)

35

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Operating Results Summary (continued)

	Six Months
	2013						2012
	Amount			Ratio			Amount			Ratio
Revenues before provision for doubtful accounts	$	18,667					$	18,352
Provision for doubtful accounts		1,777						1,835
Revenues		16,890			100.0			16,517			100.0
Salaries and benefits		7,765			46.0			7,443			45.1
Supplies		2,949			17.5			2,841			17.2
Other operating expenses		3,030			17.8			2,986			18.1
Electronic health record incentive income		(91	)		(0.5	)		(125	)		(0.8	)
Equity in earnings of affiliates		(20	)		(0.1	)		(20	)		(0.1	)
Depreciation and amortization		849			5.0			837			5.0
Interest expense		934			5.5			890			5.4
Losses on sales of facilities		12			0.1			3			—
Loss on retirement of debt		17			0.1			—			—
		15,445			91.4			14,855			89.9
Income before income taxes		1,445			8.6			1,662			10.1
Provision for income taxes		470			2.8			538			3.3
Net income		975			5.8			1,124			6.8
Net income attributable to noncontrolling interests		208			1.3			193			1.2
Net income attributable to HCA Holdings, Inc.	$	767			4.5		$	931			5.6
% changes from prior year:
Revenues		2.3	%					12.7	%
Income before income taxes		(13.1	)					68.9
Net income attributable to HCA Holdings, Inc.		(17.7	)					98.4
Admissions(a)		0.6						8.3
Equivalent admissions(b)		0.3						10.5
Revenue per equivalent admission		1.9						2.0
Same facility % changes from prior year(c):
Revenues		2.0						4.5
Admissions(a)		0.7						2.9
Equivalent admissions(b)		0.2						4.4
Revenue per equivalent admission		1.8						0.1

(a) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(b) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

(c) Same facility information excludes the operations of hospitals and their related facilities which were either acquired or divested during the current and prior period.

36

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Quarters Ended June 30, 2013 and 2012

Net income attributable to HCA Holdings, Inc. totaled $423 million, or $0.91 per diluted share, for the second quarter of 2013 compared to $391 million, or $0.85 per diluted share, for the second quarter of 2012. Shares used for diluted earnings per share were 463.2 million shares and 458.6 million shares for the quarters ended June 30, 2013 and 2012, respectively.

For the second quarter of 2013, consolidated and same facility admissions increased 1.1% and 1.3%, respectively, compared to the second quarter of 2012. Consolidated and same facility outpatient surgical volumes increased 1.1% and remained flat, respectively, during the second quarter of 2013, compared to the second quarter of 2012. Consolidated and same facility inpatient surgeries declined 0.2% and increased 0.2%, respectively, in the second quarter of 2013, compared to the second quarter of 2012. Consolidated and same facility emergency department visits increased 0.7% and 0.8%, respectively, during the quarter ended June 30, 2013, compared to the quarter ended June 30, 2012.

Revenues before provision for doubtful accounts increased 3.5% for the second quarter of 2013 compared to the second quarter of 2012. Provision for doubtful accounts declined $18 million from $1.041 billion in the second quarter of 2012 to $1.023 billion in the second quarter of 2013. The provision for doubtful accounts relates primarily to uninsured amounts due directly from patients, including copayment and deductible amounts for patients who have health care coverage. The self-pay revenue deductions for charity care and uninsured discounts increased $64 million and $398 million, respectively, during the second quarter of 2013, compared to the second quarter of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 31.2% for the second quarter of 2013, compared to 29.5% for the second quarter of 2012. At June 30, 2013, our allowance for doubtful accounts represented approximately 93% of the $5.356 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.

Revenues increased 4.2% primarily due to the combined impact of revenue per equivalent admission growth of 3.0% and a 1.1% increase in equivalent admissions for the second quarter of 2013 compared to the second quarter of 2012. Same facility revenues increased 4.0% due to the combined impact of a 2.9% increase in same facility revenue per equivalent admission and a 1.1% increase in same facility equivalent admissions for the second quarter of 2013 compared to the second quarter of 2012.

Salaries and benefits, as a percentage of revenues, were 45.5% in the second quarter of 2013 and 45.7% in the second quarter of 2012. Salaries and benefits per equivalent admission increased 2.7% in the second quarter of 2013 compared to the second quarter of 2012. Same facility labor rate increases averaged 1.5% for the second quarter of 2013 compared to the second quarter of 2012.

Supplies, as a percentage of revenues, were 17.4% in the second quarter of 2013 and 17.5% in the second quarter of 2012. Supply cost per equivalent admission increased 2.3% in the second quarter of 2013 compared to the second quarter of 2012. Supply costs per equivalent admission increased 4.5% for medical devices and 4.0% for general medical and surgical items and declined 3.3% for pharmacy supplies in the second quarter of 2013 compared to the second quarter of 2012.

Other operating expenses, as a percentage of revenues, declined to 17.8% in the second quarter of 2013 from 18.5% in the second quarter of 2012. Other operating expenses is primarily comprised of contract services,

37

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Quarters Ended June 30, 2013 and 2012 (continued)

professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. Other operating expenses include $19 million and $71 million of indigent care costs in certain Texas markets during the second quarters of 2013 and 2012, respectively. Provisions for losses related to professional liability risks were $79 million and $77 million for the second quarters of 2013 and 2012, respectively.

We recognized $52 million and $70 million of electronic health record incentive income primarily related to Medicare incentives during the second quarters of 2013 and 2012, respectively.

Equity in earnings of affiliates was $12 million and $9 million in the second quarters of 2013 and 2012, respectively.

Depreciation and amortization increased $5 million, from $420 million in the second quarter of 2012 to $425 million in the second quarter of 2013.

Interest expense increased from $448 million in the second quarter of 2012 to $462 million in the second quarter of 2013. The increase in interest expense was due to increases in the average debt balance. Our average debt balance was $28.430 billion for the second quarter of 2013 compared to $27.541 billion for the second quarter of 2012. The average effective interest rate for our long term debt was 6.5% for both of the quarters ended June 30, 2013 and 2012.

During the second quarters of 2013 and 2012, we recorded net gains on sales of facilities of $4 million and net losses on sales of facilities of $2 million, respectively.

The effective tax rates were 38.9% and 35.5% for the second quarters of 2013 and 2012, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships. Our provision for income taxes for the second quarter of 2012 was reduced by $11 million related to a reduction in interest expense related to taxing authority examinations. Excluding the effect of this adjustment, the effective tax rate for the second quarter of 2012 would have been 37.4%.

Net income attributable to noncontrolling interests increased from $94 million for the second quarter of 2012 to $114 million for the second quarter of 2013. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of hospital joint ventures in two Texas markets.

Six Months Ended June 30, 2013 and 2012

Net income attributable to HCA Holdings, Inc. totaled $767 million, or $1.66 per diluted share, in the six months ended June 30, 2013 compared to $931 million, or $2.03 per diluted share, in the six months ended June 30, 2012. The first six months of 2013 results include net losses on sales of facilities of $12 million, or $0.02 per diluted share, and a loss on retirement of debt of $17 million, or $0.02 per diluted share. The first six months of 2012 results include two Medicare revenue adjustments (and related expenses) that added $170 million to income before income taxes, or $0.22 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 462.8 million shares and 458.5 million shares for the six months ended June 30, 2013 and 2012, respectively.

For the first six months of 2013, consolidated and same facility admissions increased 0.6% and 0.7%, respectively, compared to the first six months of 2012. Consolidated and same facility outpatient surgical

38

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Six Months Ended June 30, 2013 and 2012 (continued)

volumes declined 0.9% and 2.1%, respectively, during the first six months of 2013, compared to the first six months of 2012. Consolidated and same facility inpatient surgeries declined 1.5% and 1.3%, respectively, in the first six months of 2013, compared to the first six months of 2012. Consolidated and same facility emergency department visits increased 2.1% and 2.3%, respectively, during the six months ended June 30, 2013, compared to the six months ended June 30, 2012.

Revenues before provision for doubtful accounts increased 1.7% for the first six months of 2013 compared to the first six months of 2012. Provision for doubtful accounts declined $58 million from $1.835 billion in the first six months of 2012 to $1.777 billion in the first six months of 2013. The provision for doubtful accounts relates primarily to uninsured amounts due directly from patients, including copayment and deductible amounts for patients who have health care coverage. The self-pay revenue deductions for charity care and uninsured discounts increased $171 million and $709 million, respectively, during the first six months of 2013, compared to the first six months of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 30.6% for the first six months of 2013, compared to 28.6% for the first six months of 2012. At June 30, 2013, our allowance for doubtful accounts represented approximately 93% of the $5.356 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.

Revenues increased 2.3% due to the combined impact of revenue per equivalent admission growth of 1.9% and an increase of 0.3% in equivalent admissions for the first six months of 2013 compared to the first six months of 2012. Same facility revenues increased 2.0% due to the combined impact of a 1.8% increase in same facility revenue per equivalent admission and a 0.2% increase in same facility equivalent admissions for the first six months of 2013 compared to the first six months of 2012.

Salaries and benefits, as a percentage of revenues, were 46.0% in the first six months of 2013 and 45.1% in the first six months of 2012. Salaries and benefits per equivalent admission increased 4.0% in the first six months of 2013 compared to the first six months of 2012. Same facility labor rate increases averaged 1.8% for the first six months of 2013 compared to the first six months of 2012.

Supplies, as a percentage of revenues, were 17.5% in the first six months of 2013 and 17.2% in the first six months of 2012. Supply cost per equivalent admission increased 3.5% in the first six months of 2013 compared to the first six months of 2012. Supply costs per equivalent admission increased 4.8% for medical devices and 5.4% for general medical and surgical items and declined 1.1% for pharmacy supplies in the first six months of 2013 compared to the first six months of 2012.

Other operating expenses, as a percentage of revenues, declined to 17.8% in the first six months of 2013 from 18.1% in the first six months of 2012. Other operating expenses is primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. Other operating expenses include $69 million and $151 million of indigent care costs in certain Texas markets during the first six months of 2013 and 2012, respectively. Provisions for losses related to professional liability risks were $159 million and $171 million for the first six months of 2013 and 2012, respectively.

39

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Six Months Ended June 30, 2013 and 2012 (continued)

We recognized $91 million and $125 million of electronic health record incentive income primarily related to Medicare incentives during the first six months of 2013 and 2012, respectively.

Equity in earnings of affiliates was $20 million in each of the first six months of 2013 and 2012.

Depreciation and amortization increased $12 million, from $837 million in the first six months of 2012 to $849 million in the first six months of 2013.

Interest expense increased from $890 million in the first six months of 2012 to $934 million in the first six months of 2013 which was primarily due to an increase in the average debt balance. Our average debt balance was $28.478 billion for the first six months of 2013 compared to $27.487 billion for the first six months of 2012. The average effective interest rate for our long term debt increased from 6.5% for the six months ended June 30, 2012 to 6.6% for the six months ended June 30, 2013.

During the first six months of 2013 and 2012, we recorded net losses on sales of facilities of $12 million and $3 million, respectively.

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 ⁷/₈% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

The effective tax rates were 38.0% and 36.6% for the first six months of 2013 and 2012, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships. Our provision for income taxes for the first six months of 2012 was reduced by $13 million related to a reduction in interest expense related to taxing authority examinations. Excluding the effect of this adjustment, the effective tax rate for the first six months of 2012 would have been 37.5%.

Net income attributable to noncontrolling interests increased from $193 million for the first six months of 2012 to $208 million for the first six months of 2013. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of hospital joint ventures in two Texas markets.

Liquidity and Capital Resources

Cash provided by operating activities totaled $1.554 billion in the first six months of 2013 compared to $2.257 billion in the first six months of 2012. The $703 million decline in cash provided by operating activities in the first six months of 2013 compared to the first six months of 2012 related primarily to the combined impact of the decline in net income of $149 million, a negative impact from changes in working capital items of $466 million and an increase of $85 million in income tax payments. The combined interest payments and net tax payments in the first six months of 2013 and 2012 were $1.135 billion and $995 million, respectively. Working capital totaled $1.771 billion at June 30, 2013 and $1.591 billion at December 31, 2012.

Cash used in investing activities was $790 million in the first six months of 2013 compared to $886 million in the first six months of 2012. Excluding acquisitions, capital expenditures were $896 million in the first six months of 2013 and $784 million in the first six months of 2012. We expended $23 million to acquire nonhospital health care facilities during the first six months of 2013. We expended $58 million for the acquisition of a hospital facility and $81 million to acquire nonhospital health care facilities during the first six months of

40

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Liquidity and Capital Resources (continued)

2012. Capital expenditures are expected to approximate $2.0 billion in 2013. At June 30, 2013, there were projects under construction which had estimated additional costs to complete and equip over the next five years of approximately $1.73 billion. We expect to finance capital expenditures with internally generated and borrowed funds. We received $31 million and $6 million from sales of health care entities during the first six months of 2013 and 2012, respectively. We received net cash flows from our investments of $102 million and $35 million in the first six months of 2013 and 2012, respectively.

Cash used in financing activities totaled $1.007 billion during the first six months of 2013 compared to $1.226 billion during the first six months of 2012. During the first six months of 2013, net cash flows used in financing activities included net debt repayments of $788 million, distributions to noncontrolling interests of $196 million, distributions to stockholders of $10 million, payments of debt issuance costs of $5 million and receipts of $61 million of income tax benefits for certain items (primarily related to employee exercises of stock options). During the first six months of 2012, net cash flows used in financing activities included net debt repayments of $78 million, distributions to noncontrolling interests of $191 million, distributions to stockholders of $982 million, payments of debt issuance costs of $19 million and receipts of $71 million of income tax benefits for certain items (primarily distributions to holders of our stock options).

We are a highly leveraged company with significant debt service requirements. Our debt totaled $28.200 billion at June 30, 2013. Our interest expense was $934 million for the first six months of 2013 and $890 million for the first six months of 2012.

In addition to cash flows from operations, available sources of capital include amounts available under our senior secured credit facilities ($2.985 billion and $2.645 billion available as of June 30, 2013 and July 31, 2013, respectively) and anticipated access to public and private debt markets.

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 ⁷/₈% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

Investments of our professional liability insurance subsidiaries, to maintain statutory equity and pay claims, totaled $471 million and $570 million at June 30, 2013 and December 31, 2012, respectively. An insurance subsidiary maintained net reserves for professional liability risks of $307 million and $352 million at June 30, 2013 and December 31, 2012, respectively. Our facilities are insured by a wholly-owned insurance subsidiary for losses up to $50 million per occurrence; however, this coverage is subject to a $5 million per occurrence self-insured retention. Net reserves for the self-insured professional liability risks retained were $955 million and $896 million at June 30, 2013 and December 31, 2012, respectively. Claims payments, net of reinsurance recoveries, during the next 12 months are expected to approximate $319 million. We estimate that approximately $253 million of the expected net claim payments during the next 12 months will relate to claims subject to the self-insured retention.

Management believes that cash flows from operations, amounts available under our senior secured credit facilities and our anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs during the next 12 months.

Market Risk

We are exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our wholly-owned insurance subsidiaries were $468 million and $3 million, respectively, at

41

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Liquidity and Capital Resources (continued)

Market Risk (continued)

June 30, 2013. These investments are carried at fair value, with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. At June 30, 2013, we had a net unrealized gain of $9 million on the insurance subsidiaries’ investment securities.

We are exposed to market risk related to market illiquidity. Investments in debt and equity securities of our wholly-owned insurance subsidiaries could be impaired by the inability to access the capital markets. Should the wholly-owned insurance subsidiaries require significant amounts of cash in excess of normal cash requirements to pay claims and other expenses on short notice, we may have difficulty selling these investments in a timely manner or be forced to sell them at a price less than what we might otherwise have been able to in a normal market environment. At June 30, 2013, our wholly-owned insurance subsidiaries had invested $45 million ($47 million par value) in tax-exempt student loan auction rate securities that continue to experience market illiquidity. We may be required to recognize other-than-temporary impairments on our investment securities in future periods should issuers default on interest payments or should the fair market valuations of the securities deteriorate due to ratings downgrades or other issue specific factors.

We are also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income, and changes in the fair value of derivatives which have not been designated as hedges are recorded in operations.

With respect to our interest-bearing liabilities, approximately $2.890 billion of long-term debt at June 30, 2013 was subject to variable rates of interest, while the remaining balance in long-term debt of $25.310 billion at June 30, 2013 was subject to fixed rates of interest. Both the general level of interest rates and, for the senior secured credit facilities, our leverage affect our variable interest rates. Our variable debt is comprised primarily of amounts outstanding under the senior secured credit facilities. Borrowings under the senior secured credit facilities bear interest at a rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% and (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period. The applicable margin for borrowings under the senior secured credit facilities may fluctuate according to a leverage ratio. The average effective interest rate for our long-term debt increased from 6.5% for the six months ended June 30, 2012 to 6.6% for the six months ended June 30, 2013.

The estimated fair value of our total long-term debt was $28.061 billion at June 30, 2013. The estimates of fair value are based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities. Based on a hypothetical 1% increase in interest rates, the potential annualized reduction to future pretax earnings would be approximately $29 million. To mitigate the impact of fluctuations in interest rates, we generally target a portion of our debt portfolio to be maintained at fixed rates.

Our international operations and the European term loan expose us to market risks associated with foreign currencies. In order to mitigate the currency exposure related to debt service obligations under the European term

42

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Liquidity and Capital Resources (continued)

Market Risk (continued)

loan, we have entered into a cross currency swap agreement. A cross currency swap is an agreement between two parties to exchange a stream of principal and interest payments in one currency for a stream of principal and interest payments in another currency over a specified period. Our credit risk related to this agreement is considered low because the swap agreement is with a creditworthy financial institution.

IRS Examinations

We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2010 and 2011 federal income tax returns in 2013.

Management believes HCA Holdings, Inc. and its affiliates properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS and final resolution of any disputes will not have a material, adverse effect on our results of operations or financial position. However, if payments due upon final resolution of any issues exceed our recorded estimates, such resolutions could have a material, adverse effect on our results of operations or financial position.

43

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data

	2013		2012
Number of hospitals in operation at:
March 31		162		164
June 30		161		163
September 30				162
December 31				162
Number of freestanding outpatient surgical centers in operation at:
March 31		113		109
June 30		114		110
September 30				112
December 31				112
Licensed hospital beds at(a):
March 31		41,891		41,815
June 30		41,792		41,817
September 30				41,884
December 31				41,804
Weighted average licensed beds(b):
Quarter:
First		41,867		41,740
Second		41,842		41,789
Third				41,873
Fourth				41,777
Year				41,795
Average daily census(c):
Quarter:
First		24,147		23,284
Second		22,523		22,113
Third				22,122
Fourth				22,567
Year				22,521
Admissions(d):
Quarter:
First		444,200		443,300
Second		433,000		428,200
Third				430,500
Fourth				438,700
Year				1,740,700
Equivalent admissions(e):
Quarter:
First		708,000		711,100
Second		708,700		700,800
Third				705,200
Fourth				715,000
Year				2,832,100

44

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data—(continued)

	2013			2012
Average length of stay (days)(f):
Quarter:
First		4.9			4.8
Second		4.7			4.7
Third					4.7
Fourth					4.7
Year					4.7
Emergency room visits(g):
Quarter:
First		1,749,300			1,688,400
Second		1,726,400			1,714,200
Third					1,724,000
Fourth					1,785,400
Year					6,912,000
Outpatient surgeries(h):
Quarter:
First		211,100			217,500
Second		222,200			219,800
Third					212,300
Fourth					224,000
Year					873,600
Inpatient surgeries(i):
Quarter:
First		124,700			128,300
Second		126,500			126,700
Third					124,700
Fourth					126,800
Year					506,500
Days revenues in accounts receivable(j):
Quarter:
First		52			53
Second		53			50
Third					52
Fourth					51
Year					52
Gross patient revenues(k) (dollars in millions):
Quarter:
First	$	44,791		$	41,377
Second		44,203			40,327
Third					40,125
Fourth					43,785
Year					165,614
Outpatient revenues as a % of patient revenues(l):
Quarter:
First		37	%		37	%
Second		38	%		39	%
Third					38	%
Fourth					39	%
Year					38	%

45

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data—(continued)

BALANCE SHEET DATA

	% of Accounts Receivable
	Under 91 Days			91 — 180 Days			Over 180 Days
Accounts receivable aging at June 30, 2013 (m):
Medicare and Medicaid		13	%		1	%		2	%
Managed care and other discounted		21			4			5
Uninsured		18			9			27
Total		52	%		14	%		34	%

(a) Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.

(b) Represents the average number of licensed beds, weighted based on periods owned.

(c) Represents the average number of patients in our hospital beds each day.

(d) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(e) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume.

(f) Represents the average number of days admitted patients stay in our hospitals.

(g) Represents the number of patients treated in our emergency rooms.

(h) Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.

(i) Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.

(j) Revenues per day is calculated by dividing the revenues for the period by the days in the period. Days revenues in accounts receivable is then calculated as accounts receivable, net of allowance for doubtful accounts, at the end of the period divided by the revenues per day.

(k) Gross patient revenues are based upon our standard charge listing. Gross charges/revenues typically do not reflect what our hospital facilities are paid. Gross charges/revenues are reduced by contractual adjustments, discounts and charity care to determine reported revenues.

(l) Represents the percentage of patient revenues related to patients who are not admitted to our hospitals.

(m) Accounts receivable aging data is based upon consolidated gross accounts receivable of $9.880 billion (each 1% is equivalent to approximately $99 million of gross accounts receivable).

46

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information called for by this item is provided under the caption “Market Risk” under Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

HCA’s chief executive officer and chief financial officer have reviewed and evaluated the effectiveness of HCA’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of the end of the period covered by this quarterly report. Based on that evaluation, the chief executive officer and chief financial officer have concluded HCA’s disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims or legal and regulatory proceedings could materially and adversely affect our results of operations and financial position in a given period.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

As initially disclosed in 2010, the DOJ has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other

47

than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

New Hampshire Hospital Litigation

In 2006, the Foundation for Seacoast Health (the “Foundation”) filed suit against HCA in state court in New Hampshire. The Foundation alleged that both the 2006 recapitalization transaction and a prior 1999 intra-corporate transaction violated a 1983 agreement that placed certain restrictions on transfers of the Portsmouth Regional Hospital. In May 2007, the trial court ruled against the Foundation on all its claims. On appeal, the New Hampshire Supreme Court affirmed the ruling on the 2006 recapitalization, but remanded to the trial court the claims based on the 1999 intra-corporate transaction. The trial court ruled in December 2009 that the 1999 intra-corporate transaction breached the transfer restriction provisions of the 1983 agreement. In September of 2011, the trial court issued its remedies phase decision and held that the only remedy to which the Foundation was entitled was rescission of the intra-corporate transfer that breached the transfer restriction (the Company has complied with the Court’s order, and it is not expected that such compliance will have any material effect on our operations or financial position). The Court awarded the Foundation, under the terms of the Asset Purchase Agreement, a “fraction” of its attorney fees. The Foundation appealed the remedy phase ruling, and the Company cross-appealed the liability determination. On October 31, 2011, the New Hampshire Supreme Court, on its own, raised the question whether the appeal needed to await the trial court’s further ruling on attorney fees. On November 21, 2011, after the parties briefed the issue, the New Hampshire Supreme Court dismissed the appeal as premature and remanded the case to the trial court. In February 2012, the trial court certified the case for a possible interlocutory appeal without addressing the attorney fees issue. The New Hampshire Supreme Court rejected the request for an interlocutory appeal. The parties subsequently reached a stipulation regarding the attorney fees. The trial court accepted the parties’ stipulation regarding attorneys fees and entered final judgment on liability and remedies on May 4, 2012. Both sides filed appeals with the New Hampshire Supreme Court, and briefing was completed in early February 2013. The Court heard oral argument and on July 16, 2013 issued its opinion upholding the trial court’s ruling that the Foundation does not have a right to repurchase the hospital as a result of the 1999 intra-corporate transaction. The Court further held that the breach of contract found by the trial court was not material and therefore reversed the award of attorneys fees.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010

48

reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action has also been stayed pending developments in the shareholder class actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling. The accounting for HCA’s capital expenditures and charity and uncompensated care is ongoing and will likely not be concluded before the end of 2013. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters final judgment.

General Liability and Other Claims

We are subject to claims for additional income taxes and related interest. For a description of those proceedings, see Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — IRS Examinations” and Note 3 to our condensed consolidated financial statements.

We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or for wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants have asked for punitive damages against us, which may not be covered by insurance. In the opinion of management, the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.

ITEM 1A: RISK FACTORS

Reference is made to the factors set forth under the caption “Forward-Looking Statements” in Part I, Item 2 of this Form 10-Q and other risk factors described in our annual report on Form 10-K for the year ended

49

December 31, 2012, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our annual report on Form 10-K for the year ended December 31, 2012.

ITEM 5. OTHER INFORMATION

In connection with the previously announced retirement of Richard M. Bracken as Chief Executive Officer and continued employment as Chairman of the Company, the Company entered into an Amended and Restated Employment Agreement with Mr. Bracken on August 2, 2013 (the “Amended Employment Agreement”). Pursuant to the terms of the Amended Employment Agreement, Mr. Bracken will continue to be employed by HCA Management Services, L.P., an affiliate of the Company, and shall serve as Chairman of the Company for a period commencing January 1, 2014 and ending December 31, 2014 (the “Employment Term”). The material amendments to Mr. Bracken’s prior employment agreement as set forth in the Amended Employment Agreement are described below.

Pursuant to the Amended Employment Agreement, Mr. Bracken shall receive a base salary at the monthly rate of $83,333.33 during the Employment Term (the “Base Salary”). In addition, Mr. Bracken shall be entitled to the full amount of any annual bonus earned, but unpaid, as of the effective date of the Amended Employment Agreement for the year ended December 31, 2013 under the Company’s 2013 Senior Officer Performance Excellence Program (the “PEP”). For calendar year 2014, Mr. Bracken shall be eligible to earn a bonus with a “target” payout of $750,000 based upon the achievement of certain objectives to be determined by the compensation committee of the Company or subcommittee thereof. In addition, Mr. Bracken shall receive a grant of the Company’s restricted stock units with a grant date value of $375,000 on or about the date the Company grants annual equity awards to its executive officers for calendar year 2014, which shall vest 100% upon the expiration of the Employment Term or Mr. Bracken’s sooner voluntary termination for any reason.

The Amended Employment Agreement provides that Mr. Bracken’s earned benefit pursuant to the Company’s Supplemental Executive Retirement Plan, as amended (the “SERP”), shall be frozen effective as of the close of business on December 31, 2013. The Amended Employment Agreement also provides that if Mr. Bracken is not survived by his spouse, or if Mr. Bracken’s surviving spouse is entitled to the survivor benefit pursuant to the SERP but dies before payment of her benefit has been made, the SERP benefit shall be paid to the estate of the last to survive of Mr. Bracken or his spouse in a single lump-sum payment.

Pursuant to the Amended Employment Agreement, effective as of the expiration of the Employment Term or Mr. Bracken’s sooner voluntary termination for any reason (including by reason of death or disability, but other than for “good reason” (as defined in the Amended Employment Agreement)), Mr. Bracken would be entitled to receive (i) any Base Salary that is earned and unpaid through the date of termination; (ii) any annual bonus earned, but unpaid, for the year ended December 31, 2013 under the PEP as of the date of termination; (iii) a pro rata portion of any 2014 annual bonus that Mr. Bracken would have been entitled to receive pursuant to the Amended Employment Agreement based upon the Company’s actual results for 2014 (with such proration based on the percentage of the fiscal year that shall have elapsed through the date of termination of employment, payable to Mr. Bracken when the 2014 annual bonus would have been otherwise payable (the “Prorated Bonus”)); (iv) reimbursement of any unreimbursed business expenses properly incurred; (v) continued coverage under the Company’s group health plans for Mr. Bracken and his wife until age 65; and (vi) such employee benefits, if any, as to which Mr. Bracken may be entitled under the Company’s employee benefit plans.

The Amended Employment Agreement provides that Mr. Bracken shall continue to vest with respect to any options, stock appreciation rights or restricted share units granted to Mr. Bracken under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended and restated (the “Equity Awards”), through continued service during the Employment Term. The Amended Employment Agreement further provides that each grant of Mr. Bracken’s vested Equity Awards shall remain exercisable until the earlier to occur of (a) the date that is eighteen (18) months following the termination of Mr. Bracken’s employment with the Company and (b) the expiration of the original ten (10) year term of the respective grants of such vested Equity Awards in accordance with the terms of the applicable equity award agreements.

50

If Mr. Bracken’s employment is terminated by the Company without “cause” or by Mr. Bracken for “good reason” (each as defined in the Amended Employment Agreement), Mr. Bracken would be entitled to receive the benefits described in the preceding two paragraphs and, subject to the delivery of a customary release and continued compliance with the noncompetition, nonsolicitation and confidentiality restrictions in the Amended Employment Agreement, an amount (if any) equal to Mr. Bracken’s Base Salary that would have been otherwise payable through the end of the Employment Term.

If Mr. Bracken’s employment is terminated by the Company for “cause”, Mr. Bracken would be entitled to receive the amounts and benefits described in the fourth paragraph of this section, except that Mr. Bracken would not be entitled to receive the Prorated Bonus. Mr. Bracken’s vested Equity Awards would, upon such event, remain exercisable for one hundred and eighty (180) days following the termination of Mr. Bracken’s employment.

The other terms of the Amended Employment Agreement are substantially the same as his prior employment agreement and as previously disclosed. The foregoing description of the Amended Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the Amended Employment Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

51

ITEM 6. EXHIBITS

(a) List of Exhibits:

4.1	—	Joinder Agreement, dated as of April 25, 2013, by and among HCA Inc., as borrower, Bank of America, N. A., as administrative Agent and collateral agent and the lenders party thereto (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed May 1, 2013 and incorporated herein by reference).
4.2	—	Joinder Agreement No. 2, dated as of May 3, 2013, by and among HCA Inc., as borrower, Bank of America, N. A., as administrative Agent and collateral agent and the lenders party thereto (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed May 9, 2013 and incorporated herein by reference).
4.3	—	Joinder Agreement No. 3, dated as of May 22, 2013, by and among HCA Inc., as borrower, Bank of America, N. A., as administrative Agent and collateral agent and the lenders party thereto (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed May 28, 2013 and incorporated herein by reference).
10.1	—	Amended and Restated Employment Agreement dated August 2, 2013 (Richard M. Bracken).*
31.1	—	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	—	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	—	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	—	The following financial information from our quarterly report on Form 10-Q for the quarters ended June 30, 2013 and 2012, filed with the SEC on August 6, 2013, formatted in Extensible Business Reporting Language (XBRL): (i) the condensed consolidated balance sheets at June 30, 2013 and December 31, 2012, (ii) the condensed consolidated income statements for the quarters and six months ended June 30, 2013 and 2012, (iii) the condensed consolidated comprehensive income statements for the quarters and six months ended June 30, 2013 and 2012, (iv) the condensed consolidated statements of cash flows for the six months ended June 30, 2013 and 2012 and (v) the notes to condensed consolidated financial statements.(1)

(1) The XBRL related information in Exhibit 101 to this quarterly report on Form 10-Q shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

* Management compensatory plan or arrangement.

52

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

HCA Holdings, Inc.
By:	/S/    R. MILTON JOHNSON
	R. Milton Johnson
	President and Chief Financial Officer

Date: August 6, 2013

53

EX-10.1

Exhibit 10.1

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

Richard M. Bracken

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) dated August 2, 2013 is entered into by and between HCA Holdings, Inc. (“HCA” or the “Company”) and Richard M. Bracken (the “Executive”).

In connection with the merger pursuant to that certain Agreement and Plan of Merger by and among HCA Inc., Hercules Holding II, LLC and Hercules Acquisition Corporation, dated July 24, 2006 (such transaction being the “Merger”), the Company entered into an employment agreement with Executive embodying the terms of his employment, effective as of the consummation of the Merger (the “Closing”) on November 17, 2006, as amended on January 1, 2009 and February 9, 2011 (as amended, the “Original Agreement”); and

In connection with the retirement of Executive as the Chief Executive Officer of HCA effective December 31, 2013 (the “Effective Date”) and the continued employment as the Chairman of HCA, HCA and Executive desire to amend and restate the Original Agreement in its entirety as set forth in this Agreement, such amendment and restatement to be effective as of the Effective Date (except as otherwise provided herein).

In consideration of the promises and mutual covenants herein and for other good and valuable consideration, the parties agree as follows:

1. Term of Employment; Effectiveness. Executive shall continue to be employed by HCA Management Services, L.P., an affiliate of HCA, on the terms and subject to the conditions set forth in this Agreement for a period beginning on the Effective Date and ending on December 31, 2014 (the “Employment Term”).

2. Position.

a. During the Employment Term, Executive shall serve as the Chairman of HCA. In such position, Executive shall have such duties, authority and responsibility as shall be required by and otherwise attendant to the office of Chairman and such other duties, authority and responsibility as shall be determined from time to time by the Board of Directors of HCA (the “Board”). Executive shall continue to serve as a member of the Board during the Employment Term. Upon the expiration of the Employment Term or the earlier termination of this Agreement for any reason, Executive shall be deemed resigned as an officer and employee of HCA and its affiliates effective immediately upon such event.

b. During the Employment Term, Executive will devote substantially all of such Executive’s business time and efforts to the performance of Executive’s duties hereunder and will not engage in any other business, profession or occupation for compensation or otherwise which would conflict or interfere with the rendition of such services either directly or indirectly, without the prior written consent of the Board; provided that nothing herein shall preclude Executive, subject to the prior approval of the Board, from accepting appointment to or continuing to serve on any board of directors or trustees of any business corporation or any charitable organization; provided in each case, and in the aggregate, that such activities do not conflict or interfere with the performance of Executive’s duties hereunder or conflict with Section 7.

c. It is the intent of the parties that Executive’s employment as Chairman shall not cause a “separation from service” with the Company, within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), as of the Effective Date. Accordingly, Executive shall continue to provide a level of service as an officer and employee of the Company that exceeds 20% of the average level of services performed by the Executive to the Company during the thirty-six month period immediately preceding the Effective Date.

3. Base Salary. During the Employment Term, HCA shall pay Executive a base salary at the monthly rate of $83,333.33, or such other amount as mutually agreed by Executive and HCA, payable in accordance with HCA’s normal payroll practices (the “Base Salary”).

4. Annual Bonus; Equity Participation.

a. Executive shall be entitled to the full amount of any annual bonus earned, but unpaid, as of the Effective Date for the year ended December 31, 2013 under the HCA Holdings, Inc. 2013 Senior Officer Performance Excellence Program (the “PEP”), which shall be paid to Executive in accordance with HCA’s normal payroll practices (except to the extent payment is otherwise deferred pursuant to any applicable deferred compensation arrangement with HCA).

b. Executive shall be eligible to earn, pursuant to an annual bonus program to be adopted by the Board, an annual bonus for calendar year 2014 (which shall, to the extent practicable, be paid to Executive in accordance with HCA’s normal payroll practices (except to the extent payment is otherwise deferred pursuant to any applicable deferred compensation arrangement with HCA or if otherwise agreed by HCA and Executive)), with an annualized “target” bonus payout of $750,000, or such other amount as mutually agreed by Executive and HCA, to be determined by the compensation committee of the Board or subcommittee thereof (the “Compensation Committee”). This bonus opportunity will generally be administered pursuant to the PEP or successor program, except as otherwise determined by the Compensation Committee in the event Executive is not a “covered officer” pursuant to Section 162(m) of the Code.

c. During the Employment Term, Executive shall be eligible to receive additional grants under, and otherwise to participate in, any equity incentive plan maintained by the Company, pursuant to which, on or about the date the Company grants annual equity awards to its executive officers for calendar year 2014, Executive shall receive a grant of restricted stock units of HCA with a grant date value of $375,000, which shall vest 100% upon the expiration of the Employment Term or Executive’s sooner voluntary termination for any reason.

5. Employee Benefits; Business Expenses.

a. During the Employment Term:

(i) Executive shall be entitled to participate in HCA’s pension and welfare benefit, deferred compensation, and perquisite plans as in effect from time to

2

time for senior executives of HCA other than as provided in Section 5(a)(ii) below (such plans and benefits in which he shall participate, collectively “Employee Benefits”). The full amount of such accrued benefits shall be paid to Executive under the terms of the relevant plan and any elections properly filed thereunder based on the actual date of Executive’s separation from service.

(ii) Executive’s earned benefit pursuant to the HCA Supplemental Executive Retirement Plan, as amended (the “SERP”), shall be frozen effective as of the close of business on December 31, 2013 (the “Freeze Date”). In order to effect such freeze:

(A) For clarity, the amount determined under Section 3.1(a)(i) or 3.1(b)(i) of the SERP, as applicable, will be determined based on the Executive’s Years of Service and Pay Average (each as defined in the SERP) as of the Freeze Date, and will not increase based on service completed or Compensation (as defined in the SERP) earned by the Executive after such date. In addition, the offset amount determined under Section 3.1(a)(ii) or 3.1(b)(ii) of the SERP, as applicable, will be the life annuity amount calculated as of the Freeze Date, produced by the sum of the employer-provided amount for the Executive of (1) the Executive’s accrued benefits under the Qualified Plans as of the Freeze Date, (2) the Executive’s Qualified Plans’ Distribution Amount as of the Freeze Date, (3) the Executive’s accrued benefit under the Nonqualified Plan as of the Freeze Date, and (4) the Executive’s Nonqualified Plan Distribution Amount as of the Freeze Date, utilizing the Actuarial Factors to convert any such benefit or amount to a life annuity (each capitalized term referred to in this sentence and not otherwise defined herein, as defined in the SERP). The Executive’s Benefit (as defined in the SERP) will be payable in the form of a single lump-sum payment that is the actuarial equivalent of the Benefit determined under the preceding provisions of this Section 5(a)(ii) calculated using the Actuarial Factors;

(B) Notwithstanding anything in the SERP to the contrary, and subject to Section 5.1(b) of the SERP, the survivor benefit payable to the Executive’s surviving spouse under Section 5.1(a) of the SERP shall be a single lump-sum payment equal to the Executive’s lump-sum Benefit determined under this Section 5(a)(ii). If the Executive otherwise qualifies for the survivor benefit under Section 5.1(a) of the SERP but is not survived by his spouse, or if the Executive’s surviving spouse is entitled to the survivor benefit under Section 5.1(a) of the SERP but dies before payment of her benefit has been made, the Executive’s Benefit as determined under this Section 5(a)(ii) will be paid to the estate of the last to survive of the Executive or his spouse in a single lump-sum payment equal to the Executive’s Benefit determined under this Section 5(a)(ii). Such payment will be made as soon as administratively feasible following the Executive’s death (but no later than the 15^th day of the third month following the month of the Executive’s death); and

3

(C) Notwithstanding anything in the SERP to the contrary, the Actuarial Factors used for all purposes under the SERP with respect to the Executive’s Benefit shall be (a) interest at the long-term applicable federal rate under Code Section 1274(d) as of November 1, 2012, and (b) the applicable Code Section 417(e)(3) mortality table as of the Freeze Date.

(iii) Reasonable business expenses incurred by Executive in the performance of Executive’s duties hereunder shall be reimbursed by HCA in accordance with HCA’s policies. During the Employment Term, HCA shall also provide Executive with Director’s and Officer’s indemnification and insurance coverage to the extent that the Board determines to be reasonable, in its sole discretion, for a company of the nature and size of HCA.

b. All reimbursements and in-kind benefits described in this Section 5 shall be made within the time periods set forth in Treasury Reg. § 1.409A-3(i)(1)(iv) to the extent applicable.

6. Retirement; Termination. Notwithstanding any other provision of this Agreement, the options, stock appreciation rights or restricted share units granted under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended and restated (collectively, the “New Equity”), HCA’s shareholder’s agreement or any other related agreements executed by Executive in connection with the Closing (such agreements, excluding this Agreement, collectively, the “Equity Agreements”), the provisions of this Section 6 shall exclusively govern Executive’s rights upon termination of employment with the Company and its affiliates; provided that, except as modified below, the Equity Agreements shall remain in full force and effect in accordance with their terms.

a. Effective as of the expiration of the Employment Term or Executive’s sooner voluntary termination for any reason (including by reason of death or disability, but other than for Good Reason (as defined below)):

(i) Executive shall be entitled to receive:

(A) any Base Salary earned, but unpaid, through the date of termination;

(B) any annual bonus earned, but unpaid, for the year ended December 31, 2013 under the PEP as of the date of termination, paid in accordance with Section 4(a) (except to the extent payment is otherwise deferred pursuant to any applicable deferred compensation arrangement with HCA);

(C) a pro rata portion of the annual bonus, if any, that Executive would have been entitled to receive pursuant to Section 4(b) hereof for the year in which the termination occurs, based upon HCA’s actual results for the year of termination and the percentage of the year that shall have elapsed through the date of Executive’s termination of employment, payable to Executive pursuant to Section 4(b) had Executive’s employment not terminated;

4

(D) reimbursement, within sixty (60) days following submission by Executive to HCA of appropriate supporting documentation, for any unreimbursed business expenses properly incurred by Executive in accordance with HCA policy prior to the date of Executive’s termination; so long as claims for such reimbursement (accompanied by appropriate supporting documentation) are submitted to HCA within ninety (90) days following the date of Executive’s termination of employment;

(E) continued coverage under HCA’s group health plans (on substantially the same basis as such coverage was provided immediately prior to Executive’s termination of employment) for Executive and his spouse as of the date of this Agreement until, in each case, the Executive and his spouse attains 65 years of age; and

(F) such Employee Benefits (including applicable disability, death, accrued vacation pay and SERP benefits as provided in Section 5(a)(ii)) as to which Executive may be entitled under the employee benefit plans of HCA.

(ii) For the avoidance of doubt, Executive shall continue to vest in any New Equity grants through continued service during the Employment Term. Each grant of Executive’s vested New Equity will remain exercisable until the earlier to occur of (a) the date that is eighteen (18) months following the termination of Executive’s employment with the Company and (b) the expiration of the original ten year term of the respective grants of such vested New Equity in accordance with the terms of the applicable Equity Agreements.

b. If Executive’s employment is terminated by the Company without Cause (other than by reason of Executive’s disability), or if Executive voluntarily resigns with Good Reason, Executive shall be entitled to receive the amounts and benefits described in Section 6(a) above, plus, subject to Executive’s execution and delivery of a general release of claims against the Company and its affiliates in a form reasonably acceptable to the Company and Executive’s continued compliance with the provisions of Sections 7 and 8, an amount (if any) equal to the Executive’s Base Salary that would have been otherwise payable through the end of the Employment Term (which additional amount shall be paid no later than sixty (60) days following the date of Executive’s termination of employment, provided, that the general release described above shall have been received by the Company and all applicable revocation periods shall have expired by such sixtieth (60^th) day; and, provided further, that if Executive’s employment terminates within the last sixty (60) days of a calendar year, if necessary to comply with Section 409A of the Code, such payment shall not be made prior to the first day of the next succeeding calendar year; and, provided further, that in the event any amounts must be paid over the two year period described in Section 7(c)(iii)(B) of the Original Agreement in order to comply with Section 409A of the Code, such payments shall be made in compliance with Section 409A of the Code (including any exceptions thereto as provided in Section 10(n) hereof)).

c. If Executive’s employment is terminated by the Company for Cause, Executive shall only be entitled to receive the amounts and benefits described in Section 6(a)(i) above, except that amount provided in Section 6(a)(i)(C) (relating to annual bonus) shall not be paid. Following such termination of Executive’s employment by the Company for Cause, except as set forth in this Section 6(c) or the Equity Agreements, Executive shall have no further rights to any compensation or any other benefits from the Company or any of its affiliates; provided that Executive’s vested New Equity will remain exercisable for one hundred and eighty (180) days following the termination of Executive’s employment.

5

d. For purposes of this Agreement, “Good Reason” shall mean:

(i)(I) a reduction in Executive’s Base Salary or bonus opportunities (taking into consideration equity grants under Section 4(c) hereunder as well) or (II) the reduction of benefits payable to Executive under the SERP as modified by Section 5(a)(ii), in each case other than any isolated, insubstantial and inadvertent failure by the Company that is not in bad faith and is cured within ten (10) business days after Executive gives the Company written notice of such event; or

(ii) a substantial diminution in Executive’s title, duties and responsibilities, other than any isolated, insubstantial and inadvertent failure by the Company that is not in bad faith and is cured within ten (10) business days after Executive gives the Company written notice of such event; or

(iii) a transfer of Executive’s primary workplace to a location that is more than twenty (20) miles from his or her workplace as of the date of this Agreement.

For avoidance of doubt, Executive’s change in title, duties, responsibilities, compensation (including Base Salary and bonus opportunities) and benefits as contemplated by this Agreement shall not be deemed Good Reason for purposes of the Original Agreement (or this Agreement).

e. For purposes of this Agreement, “Cause” shall mean Executive’s:

(i) willful and continued failure to perform his or her material duties with respect to the Company or it subsidiaries which continues beyond ten (10) business days after a written demand for substantial performance is delivered to Executive by the Company (the “Cure Period”); or

(ii) willful or intentional engaging by Executive in material misconduct that causes material and demonstrable injury, monetarily or otherwise, to the Company or its affiliates; or

(iii) conviction of, or a plea of nolo contendere to, a crime constituting (x) a felony under the laws of the United States or any state thereof or (y) a misdemeanor for which a sentence of more than six months’ imprisonment is imposed; or

(iv) willful and material breach of the Equity Agreements, or Executive’s engaging in any action in breach of the covenants set forth in Section 7, which continues beyond the Cure Period (to the extent that, in the Board’s reasonable judgment, such breach can be cured).

For purposes of this Section 6(e), an action will not be considered “willful” unless taken in bad faith or without the reasonable belief that it was in the best interest of HCA.

6

f. Board/Committee Resignation. Upon termination of Executive’s employment for any reason, Executive agrees to resign, as of the date of such termination and to the extent applicable, from the board of directors (and any committees thereof) of the Company or any of the Company’s affiliates to which the Executive was appointed as a result of Executive’s employment with the Company.

7. Non-Competition; Non-Solicitation.

a. Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and its affiliates and, accordingly, agrees as follows:

(i) During the Employment Term and, for a period of twenty-four (24) months following the date Executive ceases to be employed hereunder for any reason (the “Restricted Period”), Executive will not directly or indirectly:

(A) engage in any business that competes with the business of the Company or its affiliates (including businesses which the Company or its affiliates have specific plans to conduct in the future, as to which the Company or its affiliates have taken steps towards commencing and as to which Executive has participated in such planning) in any geographical area where the Company or its affiliates manufactures, produces, sells, leases, rents, licenses or otherwise provides its products or services (a “Competitive Business”);

(B) enter the employ of, or render any services to, any Person (or any division or controlled or controlling affiliate of any Person) who or which engages in a Competitive Business;

(C) acquire a financial interest in, or otherwise become actively involved with, any Competitive Business, directly or indirectly, as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant; or

(D) interfere with, or attempt to interfere with, business relationships (whether formed before, on or after the date of this Agreement) between the Company or any of its affiliates and customers, clients, or suppliers of the Company or its affiliates.

(ii) Notwithstanding anything to the contrary in this Agreement, Executive may, directly or indirectly own, solely as an investment, securities of any Person engaged in the business of the Company or its affiliates which are publicly traded on a national or regional stock exchange or quotation system or on the over-the-counter market if Executive (x) is not a controlling person of, or a member of a group which controls, such person and (y) does not, directly or indirectly, own 5% or more of any class of securities of such Person.

(iii) During the Restricted Period, Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any Person, directly or indirectly:

(A) solicit or encourage any employee of the Company or its affiliates to leave the employment of the Company or its affiliates; or

7

(B) hire any such employee who was employed by the Company or its affiliates as of the date of Executive’s termination of employment with the Company or who left the employment of the Company or its affiliates coincident with, or within one year prior to, the termination of Executive’s employment with the Company.

(iv) During the Restricted Period, Executive will not, directly or indirectly, solicit or encourage to cease to work with the Company or its affiliates any consultant then under contract with the Company or its affiliates.

b. It is expressly understood and agreed that although Executive and the Company consider the restrictions contained in this Section 7 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction against Executive, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other restrictions contained herein.

8. Confidentiality.

a. Executive will not at any time (whether during or after Executive’s employment hereunder): (i) retain or use for the benefit, purposes or account of Executive or any other Person; or (ii) disclose, divulge, reveal, communicate, share, transfer or provide access to any Person outside the Company (other than its professional advisers who are bound by confidentiality obligations), any non-public, proprietary or confidential information – including without limitation trade secrets, know-how, research and development, software, databases, inventions, processes, formulae, technology, designs and other intellectual property, information concerning finances, investments, profits, pricing, costs, products, services, vendors, customers, clients, partners, investors, personnel, compensation, recruiting, training, advertising, sales, marketing, promotions, government and regulatory activities and approvals – concerning the past, current or future business, activities and operations of the Company, its subsidiaries or affiliates and/or any third party that has disclosed or provided any of same to the Company on a confidential basis (“Confidential Information”) without the prior written authorization of the Board.

b. “Confidential Information” shall not include any information that is (i) generally known to the industry or the public other than as a result of Executive’s breach of this covenant or any breach of other confidentiality obligations by third parties; (ii) made legitimately available to Executive by a third party without breach of any confidentiality obligation; or (iii) required by law to be disclosed; provided that Executive shall give prompt written notice to the Company of such requirement, disclose no more information than is so required, and cooperate with any attempts by the Company to obtain a protective order or similar treatment.

c. Upon termination of Executive’s employment hereunder, Executive shall (i) cease and not thereafter commence use of any Confidential Information or intellectual

8

property (including without limitation, any patent, invention, copyright, trade secret, trademark, trade name, logo, domain name or other source indicator) owned or used by the Company, its subsidiaries or affiliates; (ii) immediately destroy, delete, or return to the Company, at the Company’s option, all originals and copies in any form or medium (including memoranda, books, papers, plans, computer files, letters and other data) in Executive’s possession or control (including any of the foregoing stored or located in Executive’s office, home, laptop or other computer, whether or not Company property) that contain Confidential Information or otherwise relate to the business of the Company, its affiliates and subsidiaries, except that Executive may retain only those portions of any personal notes, notebooks and diaries (including Executive’s personal rolodex) that do not contain any Confidential Information; and (iii) notify and fully cooperate with the Company regarding the delivery or destruction of any other Confidential Information of which Executive is or becomes aware.

9. Specific Performance. Executive acknowledges and agrees that the Company’s remedies at law for a breach or threatened breach of any of the provisions of Section 7 or Section 8 would be inadequate and the Company would suffer irreparable damages as a result of such breach or threatened breach. In recognition of this fact, Executive agrees that, in the event of such a breach or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to cease making any payments or providing any benefit otherwise required by this Agreement and obtain equitable relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available.

10. Miscellaneous.

a. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Tennessee, without regard to conflicts of laws principles thereof.

b. Dispute Resolution. Except as otherwise provided in Section 9 of this Agreement, any controversy, dispute, or claim arising out of, in connection with, or in relation to, the interpretation, performance or breach of this Agreement, including, without limitation, the validity, scope, and enforceability of this section, may at the election of any party, be solely and finally settled by arbitration conducted in Nashville, Tennessee, by and in accordance with the then existing rules for commercial arbitration of the American Arbitration Association, or any successor organization and with the Expedited Procedures thereof (collectively, the “Rules”). Each of the parties hereto agrees that such arbitration shall be conducted by a single arbitrator selected in accordance with the Rules; provided that such arbitrator shall be experienced in deciding cases concerning the matter which is the subject of the dispute. Any of the parties may demand arbitration by written notice to the other and to the Arbitrator set forth in this Section 10(b) (“Demand for Arbitration”). Each of the parties agrees that if possible, the award shall be made in writing no more than thirty (30) days following the end of the proceeding. Any award rendered by the arbitrator(s) shall be final and binding and judgment may be entered on it in any court of competent jurisdiction. Each of the parties hereto agrees to treat as confidential the results of any arbitration (including, without limitation, any findings of fact and/or law made by the arbitrator) and not to disclose such results to any unauthorized person. The parties intend that this agreement to arbitrate be valid, enforceable and irrevocable. In the event of any arbitration

9

with regard to this Agreement, each party shall pay its own legal fees and expenses, provided, however, that the parties agree to share the cost of the Arbitrator’s fees. If Executive substantially prevails on any of his substantive legal claims, then the Company shall pay all legal fees incurred by Executive to arbitrate the dispute, and all arbitration fees.

c. Entire Agreement/Amendments. This Agreement contains the entire understanding of the parties with respect to the employment of Executive hereunder. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other than those expressly set forth herein. This Agreement may not be altered, modified, or amended except by written instrument signed by the parties hereto.

d. No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.

e. Severability. In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby.

f. Assignment. This Agreement, and all of Executive’s rights and duties hereunder, shall not be assignable or delegable by Executive. Any purported assignment or delegation by Executive in violation of the foregoing shall be null and void ab initio and of no force and effect. This Agreement may be assigned by the Company to a person or entity which is (i) an affiliate of the Company, so long as such affiliate maintains sufficient assets to satisfy the Company’s obligation hereunder, (ii) a successor in interest to substantially all of the business operations of the Company. Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and obligations of such successor person or entity.

g. No Set Off; No Mitigation. The Company’s obligation to pay Executive the amounts provided and to make the arrangements provided hereunder shall not be subject to set-off, counterclaim or recoupment of amounts owed by Executive to the Company or its affiliates. Executive shall not be required to mitigate the amount of any payment provided for pursuant to this Agreement by seeking other employment, taking into account the provisions of Section 7 of this Agreement.

h. Successors; Binding Agreement. This Agreement shall inure to the benefit of and be binding upon personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

i. Notice. For the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three (3) days after it has been mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth below in this Agreement, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.

10

If to HCA Holdings, Inc., to

HCA Holdings, Inc.

One Park Plaza

Nashville, TN 37203

Attn: General Counsel

Telecopy: (615) 344-1531

If to Executive:

To the Executive’s address of record on the books of the Company.

j. Prior Agreements. This Agreement supersedes all prior agreements and understandings (including verbal agreements) between Executive and the Company and/or its affiliates regarding the terms and conditions of Executive’s employment with the Company and/or its affiliates.

k. Cooperation. Executive shall provide Executive’s reasonable cooperation in connection with any action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive’s employment hereunder. The Company shall pay to Executive reasonable fees, and reimburse Executive’s reasonable related business expenses incurred by Executive in connection with Executive’s provision of such services. This provision shall survive any termination of this Agreement.

l. Withholding Taxes. The Company may withhold from any amounts payable under this Agreement such Federal, state and local taxes as may be required to be withheld pursuant to any applicable law or regulation.

m. Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

n. Compliance with Section 409A. This Agreement is intended to comply with Section 409A of the Code and will be so interpreted. Furthermore, it is intended that each payment or installment of payments provided under this Agreement is a separate “payment” for purposes of Section 409A of the Code, and that each such payment satisfies, to the greatest extent possible, an exemption from the application of Section 409A of the Code, including those provided under Treasury Regulations 1.409A-1(b)(4) (regarding short-term deferrals), 1.409A-1(b)(9)(iii) (regarding the two-times, two year severance exception), and 1.409A-1(b)(9)(v) (regarding reimbursements and other separation pay). Notwithstanding anything herein to the contrary, (i) if at the time of Executive’s termination of employment hereunder Executive is a “specified employee” as defined in Section 409A of the Code, and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in order to prevent the imposition of any accelerated or

11

additional tax under Section 409A of the Code, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to Executive) until the date that is six months following Executive’s termination of employment with the Company (or the earliest date as is permitted under Section 409A of the Code) and (ii) if any other payments of money or other benefits due to Executive hereunder could cause the application of an accelerated or additional tax under Section 409A of the Code, the parties agree to restructure the payments or benefits to comply with Section 409A of the Code in a manner which does not diminish the value of such payments and benefits to the Executive.

o. Future Change in Control. The Company and the Executive agree to work together in good faith to try to address any issues posed by Sections 280G and 4999 of the Code that could arise as a result of a change in control of HCA (within the meaning of Section 280G of the Code) that occurs after the Closing.

p. Equity Adjustment. The Company agrees to indemnify Executive against any adverse tax consequences (including, without limitation, under Section 409A of the Code), if any, that result from the adjustment by the Company of stock options, stock appreciation rights or restricted stock units held by the Executive in connection with the payment of any extraordinary cash dividends after the Closing.

[Remainder of Page Intentional Left Blank]

12

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.

HCA HOLDINGS, INC.	RICHARD M. BRACKEN
/s/ John M. Steele	/s/ Richard M. Bracken
By:     John M. Steele
Title:  Senior Vice President-Human Resources

13

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Richard M. Bracken, certify that:

1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    RICHARD M. BRACKEN
	RICHARD M. BRACKEN
	Chairman of the Board and Chief Executive Officer

Date: August 6, 2013

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, R. Milton Johnson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/S/    R. MILTON JOHNSON
	R. MILTON JOHNSON
	President and Chief Financial Officer

Date: August 6, 2013

EX-32

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HCA Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/    RICHARD M. BRACKEN
	RICHARD M. BRACKEN
	Chairman of the Board and Chief Executive Officer

August 6, 2013

By:	/s/    R. MILTON JOHNSON
	R. MILTON JOHNSON
	President and Chief Financial Officer

August 6, 2013

XML

Segment and Geographic Information

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Segment and Geographic Information

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The National Group includes 77 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group includes 78 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses (gains) on sales of facilities, loss on retirement of debt, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter						Six Months
	2013			2012			2013			2012
Revenues:
National Group	$	3,964		$	3,806		$	7,945		$	7,798
American Group		4,065			3,966			8,099			8,051
Corporate and other		421			340			846			668
	$	8,450		$	8,112		$	16,890		$	16,517
Equity in earnings of affiliates:
National Group	$	(3	)	$	(3	)	$	(5	)	$	(7	)
American Group		(7	)		(7	)		(13	)		(14	)
Corporate and other		(2	)		1			(2	)		1
	$	(12	)	$	(9	)	$	(20	)	$	(20	)
Adjusted segment EBITDA:
National Group	$	831		$	789		$	1,635		$	1,710
American Group		916			841			1,744			1,814
Corporate and other		(58	)		(61	)		(122	)		(132	)
	$	1,689		$	1,569		$	3,257		$	3,392
Depreciation and amortization:
National Group	$	177		$	176		$	351		$	349
American Group		202			202			404			405
Corporate and other		46			42			94			83
	$	425		$	420		$	849		$	837
Adjusted segment EBITDA	$	1,689		$	1,569		$	3,257		$	3,392
Depreciation and amortization		425			420			849			837
Interest expense		462			448			934			890
Losses (gains) on sales of facilities		(4	)		2			12			3
Loss on retirement of debt		—			—			17			—
Income before income taxes	$	806		$	699		$	1,445		$	1,662

XML

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail) (Senior Unsecured Notes Due 2021 [Member], USD $) In Millions, unless otherwise specified	Dec. 06, 2012	Nov. 23, 2010
Senior Unsecured Notes Due 2021 [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,525
Debt instrument, stated interest	6.25%	7.75%

XML

Condensed Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 462	$ 705
Accounts receivable, less allowance for doubtful accounts of $4,965 and $4,846	4,915	4,672
Inventories	1,152	1,086
Deferred income taxes	401	385
Other	861	915
Total current assets	7,791	7,763
Property and equipment, at cost	30,077	29,527
Accumulated depreciation	(16,848)	(16,342)
Property and equipment, net	13,229	13,185
Investments of insurance subsidiaries	405	515
Investments in and advances to affiliates	120	104
Goodwill and other intangible assets	5,534	5,539
Deferred loan costs	264	290
Other	591	679
Total assets	27,934	28,075
Current liabilities:
Accounts payable	1,657	1,768
Accrued salaries	1,036	1,120
Other accrued expenses	1,871	1,849
Long-term debt due within one year	1,456	1,435
Total current liabilities	6,020	6,172
Long-term debt	26,744	27,495
Professional liability risks	960	973
Income taxes and other liabilities	1,695	1,776
Stockholders' deficit:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 447,066,900 shares in 2013 and 443,200,200 shares in 2012	4	4
Capital in excess of par value	1,792	1,753
Accumulated other comprehensive loss	(426)	(457)
Retained deficit	(10,193)	(10,960)
Stockholders' deficit attributable to HCA Holdings, Inc.	(8,823)	(9,660)
Noncontrolling interests	1,338	1,319
Total stockholders' deficit	(7,485)	(8,341)
Total liabilities and stockholders' deficit	$ 27,934	$ 28,075

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

Earnings Per Share

NOTE 4 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share for the quarters and six months ended June 30, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	Quarter				Six Months
	2013		2012		2013		2012
Net income attributable to HCA Holdings, Inc.	$	423	$	391	$	767	$	931
Weighted average common shares outstanding		446,612		439,473		445,513		438,705
Effect of dilutive incremental shares		16,572		19,148		17,269		19,762
Shares used for diluted earnings per share		463,184		458,621		462,782		458,467
Earnings per share:
Basic earnings per share	$	0.95	$	0.89	$	1.72	$	2.12
Diluted earnings per share	$	0.91	$	0.85	$	1.66	$	2.03

XML

Assets and Liabilities Measured at Fair Value (Tables)

6 Months Ended

Jun. 30, 2013

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of June 30, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	June 30, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	394		$	—		$	394		$	—
Auction rate securities		45			—			—			45
Asset-backed securities		12			—			12			—
Money market funds		17			17			—			—
		468			17			406			45
Equity securities		3			2			—			1
Investments of insurance subsidiaries		471			19			406			46
Less amounts classified as current assets		(66	)		(17	)		(49	)		—
	$	405		$	2		$	357		$	46
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	17		$	—		$	17		$	—
Interest rate swaps (Income taxes and other liabilities)		325			—			325			—

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the six months ended June 30, 2013 (dollars in millions):

Asset balances at December 31, 2012	$	70
Unrealized gains included in other comprehensive income		3
Settlements		(27	)
Asset balances at June 30, 2013	$	46

XML

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income (loss)	$ 975	$ 1,124
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(2,335)	(1,927)
Provision for doubtful accounts	1,777	1,835
Depreciation and amortization	849	837
Income taxes	183	326
Losses (gains) on sales of facilities	12	3
Loss on retirement of debt	17
Amortization of deferred loan costs	28	29
Share-based compensation	51	23
Equity in earnings of affiliates	(20)	(20)
Other	(3)	7
Net cash provided by operating activities	1,554	2,257
Cash flows from investing activities:
Purchase of property and equipment	(896)	(784)
Acquisition of hospitals and health care entities	(23)	(139)
Disposition of hospitals and health care entities	31	6
Change in investments	102	35
Other	(4)	(4)
Net cash used in investing activities	(790)	(886)
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving bank credit facilities	(20)	(820)
Repayment of long-term debt	(768)	(608)
Distributions to noncontrolling interests	(196)	(191)
Payment of debt issuance costs	(5)	(19)
Distributions to stockholders	(10)	(982)
Changes in intercompany balances with affiliates, net
Income tax benefits	61	71
Other	(69)	(27)
Net cash used in financing activities	(1,007)	(1,226)
Change in cash and cash equivalents	(243)	145
Cash and cash equivalents at beginning of period	705	373
Cash and cash equivalents at end of period	462	518
HCA Holdings, Inc. Issuer [Member]
Cash flows from operating activities:
Net income (loss)	798	931
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	41
Provision for doubtful accounts
Depreciation and amortization
Income taxes	183	326
Losses (gains) on sales of facilities
Loss on retirement of debt
Amortization of deferred loan costs	2	1
Share-based compensation	51	23
Equity in earnings of affiliates	(860)	(969)
Other
Net cash provided by operating activities	215	312
Cash flows from investing activities:
Purchase of property and equipment
Acquisition of hospitals and health care entities
Disposition of hospitals and health care entities
Change in investments
Other
Net cash used in investing activities
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt
Distributions to noncontrolling interests
Payment of debt issuance costs
Distributions to stockholders	(10)	(982)
Changes in intercompany balances with affiliates, net	(216)	628
Income tax benefits	61	71
Other	(72)	(29)
Net cash used in financing activities	(237)	(312)
Change in cash and cash equivalents	(22)
Cash and cash equivalents at beginning of period	22
Cash and cash equivalents at end of period
HCA Inc. Issuer [Member]
Cash flows from operating activities:
Net income (loss)	(694)	(673)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(18)	12
Provision for doubtful accounts
Depreciation and amortization
Income taxes
Losses (gains) on sales of facilities
Loss on retirement of debt	17
Amortization of deferred loan costs	26	28
Share-based compensation
Equity in earnings of affiliates
Other	4	8
Net cash provided by operating activities	(665)	(625)
Cash flows from investing activities:
Purchase of property and equipment
Acquisition of hospitals and health care entities
Disposition of hospitals and health care entities
Change in investments
Other
Net cash used in investing activities
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving bank credit facilities	(20)	(820)
Repayment of long-term debt	(726)	(545)
Distributions to noncontrolling interests
Payment of debt issuance costs	(5)	(19)
Distributions to stockholders
Changes in intercompany balances with affiliates, net	1,416	659
Income tax benefits
Other
Net cash used in financing activities	665	625
Change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Subsidiary Guarantors [Member]
Cash flows from operating activities:
Net income (loss)	1,125	1,226
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(1,217)	(995)
Provision for doubtful accounts	1,051	1,021
Depreciation and amortization	420	409
Income taxes
Losses (gains) on sales of facilities	19	3
Loss on retirement of debt
Amortization of deferred loan costs
Share-based compensation
Equity in earnings of affiliates	(2)	(3)
Other		(1)
Net cash provided by operating activities	1,398	1,663
Cash flows from investing activities:
Purchase of property and equipment	(434)	(408)
Acquisition of hospitals and health care entities		(72)
Disposition of hospitals and health care entities	17	1
Change in investments	5	(8)
Other	(1)	(1)
Net cash used in investing activities	(413)	(488)
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt	(22)	(16)
Distributions to noncontrolling interests	(29)	(36)
Payment of debt issuance costs
Distributions to stockholders
Changes in intercompany balances with affiliates, net	(1,165)	(1,115)
Income tax benefits
Other
Net cash used in financing activities	(1,216)	(1,167)
Change in cash and cash equivalents	(231)	8
Cash and cash equivalents at beginning of period	383	115
Cash and cash equivalents at end of period	152	123
Subsidiary Non-Guarantors [Member]
Cash flows from operating activities:
Net income (loss)	606	609
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(1,141)	(944)
Provision for doubtful accounts	726	814
Depreciation and amortization	429	428
Income taxes
Losses (gains) on sales of facilities	(7)
Loss on retirement of debt
Amortization of deferred loan costs
Share-based compensation
Equity in earnings of affiliates	(18)	(17)
Other	(7)
Net cash provided by operating activities	606	907
Cash flows from investing activities:
Purchase of property and equipment	(462)	(376)
Acquisition of hospitals and health care entities	(23)	(67)
Disposition of hospitals and health care entities	14	5
Change in investments	97	43
Other	(3)	(3)
Net cash used in investing activities	(377)	(398)
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt	(20)	(47)
Distributions to noncontrolling interests	(167)	(155)
Payment of debt issuance costs
Distributions to stockholders
Changes in intercompany balances with affiliates, net	(35)	(172)
Income tax benefits
Other	3	2
Net cash used in financing activities	(219)	(372)
Change in cash and cash equivalents	10	137
Cash and cash equivalents at beginning of period	300	258
Cash and cash equivalents at end of period	310	395
Eliminations [Member]
Cash flows from operating activities:
Net income (loss)	(860)	(969)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities
Provision for doubtful accounts
Depreciation and amortization
Income taxes
Losses (gains) on sales of facilities
Loss on retirement of debt
Amortization of deferred loan costs
Share-based compensation
Equity in earnings of affiliates	860	969
Other
Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property and equipment
Acquisition of hospitals and health care entities
Disposition of hospitals and health care entities
Change in investments
Other
Net cash used in investing activities
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt
Distributions to noncontrolling interests
Payment of debt issuance costs
Distributions to stockholders
Changes in intercompany balances with affiliates, net
Income tax benefits
Other
Net cash used in financing activities
Change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

XML

Supplemental Condensed Consolidating Financial Information

6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Supplemental Condensed Consolidating Financial Information

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7  ³/₄% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, wholly-owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).

Our summarized condensed consolidating comprehensive income statements for the quarters and six months ended June 30, 2013 and 2012, condensed consolidating balance sheets at June 30, 2013 and December 31, 2012 and condensed consolidating statements of cash flows for the six months ended June 30, 2013 and 2012, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	5,012		$	4,461		$	—		$	9,473
Provision for doubtful accounts		—			—			608			415			—			1,023
Revenues		—			—			4,404			4,046			—			8,450
Salaries and benefits		—			—			2,058			1,790			—			3,848
Supplies		—			—			776			694			—			1,470
Other operating expenses		1			—			757			749			—			1,507
Electronic health record incentive income		—			—			(33	)		(19	)		—			(52	)
Equity in earnings of affiliates		(504	)		—			(1	)		(11	)		504			(12	)
Depreciation and amortization		—			—			211			214			—			425
Interest expense		51			544			(109	)		(24	)		—			462
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Management fees		—			—			(181	)		181			—			—
		(452	)		544			3,481			3,567			504			7,644
Income (loss) before income taxes		452			(544	)		923			479			(504	)		806
Provision (benefit) for income taxes		(20	)		(213	)		354			148			—			269
Net income (loss)		472			(331	)		569			331			(504	)		537
Net income attributable to noncontrolling interests		—			—			16			98			—			114
Net income (loss) attributable to HCA Holdings, Inc.	$	472		$	(331	)	$	553		$	233		$	(504	)	$	423
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	472		$	(283	)	$	558		$	229		$	(504	)	$	472

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,753		$	4,400		$	—		$	9,153
Provision for doubtful accounts		—			—			558			483			—			1,041
Revenues		—			—			4,195			3,917			—			8,112
Salaries and benefits		—			—			1,951			1,756			—			3,707
Supplies		—			—			738			684			—			1,422
Other operating expenses		—			—			751			742			—			1,493
Electronic health record incentive income		—			—			(48	)		(22	)		—			(70	)
Equity in earnings of affiliates		(409	)		—			(1	)		(8	)		409			(9	)
Depreciation and amortization		—			—			209			211			—			420
Interest expense		30			529			(85	)		(26	)		—			448
Losses on sales of facilities		—			—			2			—			—			2
Management fees		—			—			(168	)		168			—			—
		(379	)		529			3,349			3,505			409			7,413
Income (loss) before income taxes		379			(529	)		846			412			(409	)		699
Provision (benefit) for income taxes		(12	)		(189	)		297			118			—			214
Net income (loss)		391			(340	)		549			294			(409	)		485
Net income attributable to noncontrolling interests		—			—			16			78			—			94
Net income (loss) attributable to HCA Holdings, Inc.	$	391		$	(340	)	$	533		$	216		$	(409	)	$	391
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	391		$	(369	)	$	538		$	202		$	(409	)	$	353

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	9,884		$	8,783		$	—		$	18,667
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Revenues		—			—			8,833			8,057			—			16,890
Salaries and benefits		—			—			4,185			3,580			—			7,765
Supplies		—			—			1,567			1,382			—			2,949
Other operating expenses		2			—			1,489			1,539			—			3,030
Electronic health record incentive income		—			—			(62	)		(29	)		—			(91	)
Equity in earnings of affiliates		(860	)		—			(2	)		(18	)		860			(20	)
Depreciation and amortization		—			—			420			429			—			849
Interest expense		97			1,102			(215	)		(50	)		—			934
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(364	)		364			—			—
		(761	)		1,119			7,037			7,190			860			15,445
Income (loss) before income taxes		761			(1,119	)		1,796			867			(860	)		1,445
Provision (benefit) for income taxes		(37	)		(425	)		671			261			—			470
Net income (loss)		798			(694	)		1,125			606			(860	)		975
Net income attributable to noncontrolling interests		—			—			29			179			—			208
Net income (loss) attributable to HCA Holdings, Inc.	$	798		$	(694	)	$	1,096		$	427		$	(860	)	$	767
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	798		$	(630	)	$	1,105		$	385		$	(860	)	$	798

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	9,656		$	8,696		$	—		$	18,352
Provision for doubtful accounts		—			—			1,021			814			—			1,835
Revenues		—			—			8,635			7,882			—			16,517
Salaries and benefits		—			—			3,933			3,510			—			7,443
Supplies		—			—			1,491			1,350			—			2,841
Other operating expenses		—			4			1,480			1,502			—			2,986
Electronic health record incentive income		—			—			(89	)		(36	)		—			(125	)
Equity in earnings of affiliates		(969	)		—			(3	)		(17	)		969			(20	)
Depreciation and amortization		—			—			409			428			—			837
Interest expense		60			1,058			(176	)		(52	)		—			890
Losses on sales of facilities		—			—			3			—			—			3
Management fees		—			—			(328	)		328			—			—
		(909	)		1,062			6,720			7,013			969			14,855
Income (loss) before income taxes		909			(1,062	)		1,915			869			(969	)		1,662
Provision (benefit) for income taxes		(22	)		(389	)		689			260			—			538
Net income (loss)		931			(673	)		1,226			609			(969	)		1,124
Net income attributable to noncontrolling interests		—			—			33			160			—			193
Net income (loss) attributable to HCA Holdings, Inc.	$	931		$	(673	)	$	1,193		$	449		$	(969	)	$	931
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	931		$	(698	)	$	1,202		$	456		$	(969	)	$	922

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	152		$	310	$	—		$	462
Accounts receivable, net		—			—			2,492			2,423		—			4,915
Inventories		—			—			683			469		—			1,152
Deferred income taxes		401			—			—			—		—			401
Other		—			—			309			552		—			861
		401			—			3,636			3,754		—			7,791
Property and equipment, net		—			—			7,432			5,797		—			13,229
Investments of insurance subsidiaries		—			—			—			405		—			405
Investments in and advances to affiliates		19,341			—			15			105		(19,341	)		120
Goodwill and other intangible assets		—			—			1,695			3,839		—			5,534
Deferred loan costs		31			233			—			—		—			264
Other		362			—			26			203		—			591
	$	20,135		$	233		$	12,804		$	14,103	$	(19,341	)	$	27,934
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,090		$	567	$	—		$	1,657
Accrued salaries		—			—			601			435		—			1,036
Other accrued expenses		261			375			460			775		—			1,871
Long-term debt due within one year		—			1,381			43			32		—			1,456
		261			1,756			2,194			1,809		—			6,020
Long-term debt		2,525			23,555			174			490		—			26,744
Intercompany balances		25,729			(10,782	)		(18,290	)		3,343		—			—
Professional liability risks		—			—			—			960		—			960
Income taxes and other liabilities		443			342			674			236		—			1,695
		28,958			14,871			(15,248	)		6,838		—			35,419
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,823	)		(14,638	)		27,952			6,027		(19,341	)		(8,823	)
Noncontrolling interests		—			—			100			1,238		—			1,338
		(8,823	)		(14,638	)		28,052			7,265		(19,341	)		(7,485	)
	$	20,135		$	233		$	12,804		$	14,103	$	(19,341	)	$	27,934

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	798		$	(694	)	$	1,125		$	606		$	(860	)	$	975
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		41			(18	)		(1,217	)		(1,141	)		—			(2,335	)
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Depreciation and amortization		—			—			420			429			—			849
Income taxes		183			—			—			—			—			183
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		2			26			—			—			—			28
Share-based compensation		51			—			—			—			—			51
Equity in earnings of affiliates		(860	)		—			—			—			860			—
Other		—			4			—			(7	)		—			(3	)
Net cash provided by (used in) operating activities		215			(665	)		1,398			606			—			1,554
Cash flows from investing activities:
Purchase of property and equipment		—			—			(434	)		(462	)		—			(896	)
Acquisition of hospitals and health care entities		—			—			—			(23	)		—			(23	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			5			97			—			102
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(413	)		(377	)		—			(790	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			(20	)		—			—			—			(20	)
Repayment of long-term debt		—			(726	)		(22	)		(20	)		—			(768	)
Distributions to noncontrolling interests		—			—			(29	)		(167	)		—			(196	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(216	)		1,416			(1,165	)		(35	)		—			—
Income tax benefits		61			—			—			—			—			61
Other		(72	)		—			—			3			—			(69	)
Net cash (used in) provided by financing activities		(237	)		665			(1,216	)		(219	)		—			(1,007	)
Change in cash and cash equivalents		(22	)		—			(231	)		10			—			(243	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	152		$	310		$	—		$	462

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	931		$	(673	)	$	1,226		$	609		$	(969	)	$	1,124
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		—			12			(995	)		(944	)		—			(1,927	)
Provision for doubtful accounts		—			—			1,021			814			—			1,835
Depreciation and amortization		—			—			409			428			—			837
Income taxes		326			—			—			—			—			326
Losses on sales of facilities		—			—			3			—			—			3
Amortization of deferred loan costs		1			28			—			—			—			29
Share-based compensation		23			—			—			—			—			23
Equity in earnings of affiliates		(969	)		—			—			—			969			—
Other		—			8			(1	)		—			—			7
Net cash provided by (used in) operating activities		312			(625	)		1,663			907			—			2,257
Cash flows from investing activities:
Purchase of property and equipment		—			—			(408	)		(376	)		—			(784	)
Acquisition of hospitals and health care entities		—			—			(72	)		(67	)		—			(139	)
Disposition of hospitals and health care entities		—			—			1			5			—			6
Change in investments		—			—			(8	)		43			—			35
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(488	)		(398	)		—			(886	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(820	)		—			—			—			(820	)
Repayment of long-term debt		—			(545	)		(16	)		(47	)		—			(608	)
Distributions to noncontrolling interests		—			—			(36	)		(155	)		—			(191	)
Payment of debt issuance costs		—			(19	)		—			—			—			(19	)
Distributions to stockholders		(982	)		—			—			—			—			(982	)
Changes in intercompany balances with affiliates, net		628			659			(1,115	)		(172	)		—			—
Income tax benefits		71			—			—			—			—			71
Other		(29	)		—			—			2			—			(27	)
Net cash (used in) provided by financing activities		(312	)		625			(1,167	)		(372	)		—			(1,226	)
Change in cash and cash equivalents		—			—			8			137			—			145
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	123		$	395		$	—		$	518

XML

Capital Structure - Schedule of Changes in Stockholders' Deficit and Equity (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Capital Structure [Line Items]
Beginning Balance			$ (8,341)
Net income	537	485	975	1,124
Other comprehensive income	49	(38)	31	(9)
Distributions			(196)
Share-based benefit plans			41
Other			5
Ending Balance	(7,485)		(7,485)
Common Stock [Member]
Capital Structure [Line Items]
Beginning Balance			4
Net income
Other comprehensive income
Distributions
Share-based benefit plans
Other
Ending Balance	4		4
Beginning Balance, Shares			443,200
Share-based benefit plans, Shares			3,867
Ending Balance, Shares	447,067		447,067
Capital in Excess of Par Value [Member]
Capital Structure [Line Items]
Beginning Balance			1,753
Net income
Other comprehensive income
Distributions
Share-based benefit plans			41
Other			(2)
Ending Balance	1,792		1,792
Accumulated Other Comprehensive Loss [Member]
Capital Structure [Line Items]
Beginning Balance			(457)
Net income
Other comprehensive income			31
Distributions
Share-based benefit plans
Other
Ending Balance	(426)		(426)
Retained Deficit [Member]
Capital Structure [Line Items]
Beginning Balance			(10,960)
Net income			767
Other comprehensive income
Distributions
Share-based benefit plans
Other
Ending Balance	(10,193)		(10,193)
Equity Attributable to Noncontrolling Interests [Member]
Capital Structure [Line Items]
Beginning Balance			1,319
Net income			208
Other comprehensive income
Distributions			(196)
Share-based benefit plans
Other			7
Ending Balance	$ 1,338		$ 1,338

XML

Financial Instruments - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Offsetting [Abstract]
Estimated amount reclassified from other comprehensive income to interest expense	$ 125
Estimated termination value if there is breach of provision related to derivative agreement	$ 358

XML

Segment and Geographic Information (Tables)

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA, Depreciation and Amortization and Assets

The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter						Six Months
	2013			2012			2013			2012
Revenues:
National Group	$	3,964		$	3,806		$	7,945		$	7,798
American Group		4,065			3,966			8,099			8,051
Corporate and other		421			340			846			668
	$	8,450		$	8,112		$	16,890		$	16,517
Equity in earnings of affiliates:
National Group	$	(3	)	$	(3	)	$	(5	)	$	(7	)
American Group		(7	)		(7	)		(13	)		(14	)
Corporate and other		(2	)		1			(2	)		1
	$	(12	)	$	(9	)	$	(20	)	$	(20	)
Adjusted segment EBITDA:
National Group	$	831		$	789		$	1,635		$	1,710
American Group		916			841			1,744			1,814
Corporate and other		(58	)		(61	)		(122	)		(132	)
	$	1,689		$	1,569		$	3,257		$	3,392
Depreciation and amortization:
National Group	$	177		$	176		$	351		$	349
American Group		202			202			404			405
Corporate and other		46			42			94			83
	$	425		$	420		$	849		$	837
Adjusted segment EBITDA	$	1,689		$	1,569		$	3,257		$	3,392
Depreciation and amortization		425			420			849			837
Interest expense		462			448			934			890
Losses (gains) on sales of facilities		(4	)		2			12			3
Loss on retirement of debt		—			—			17			—
Income before income taxes	$	806		$	699		$	1,445		$	1,662

XML

Capital Structure (Tables)

6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Schedule of Changes in Stockholders' Deficit and Equity

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		Par Value
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			767			208			975
Other comprehensive income		—		—		—			31			—			—			31
Distributions		—		—		—			—			—			(196	)		(196	)
Share-based benefit plans		3,867		—		41			—			—			—			41
Other		—		—		(2	)		—			—			7			5
Balances at June 30, 2013		447,067	$	4	$	1,792		$	(426	)	$	(10,193	)	$	1,338		$	(7,485	)

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities			Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11		$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(5	)		—			—			—			(5	)
Foreign currency translation adjustments, net of $21 income tax benefit		—			(39	)		—			—			(39	)
Change in fair value of derivative instruments, net of $15 of income taxes		—			—			—			25			25
Expense reclassified into operations from other comprehensive income, net of $6 and $23, respectively, income tax benefits		—			—			9			41			50
Balances at June 30, 2013	$	6		$	(40	)	$	(187	)	$	(205	)	$	(426	)

XML

Long-Term Debt - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2013	Mar. 31, 2013	Jun. 30, 2012	Jun. 30, 2013
Proforma Debt Instrument [Line Items]
Pretax loss on retirement of debt		$ 17		$ (17)
Senior Secured Second Lien Notes Due 2017 [Member]
Proforma Debt Instrument [Line Items]
Redemption of aggregate principal amount		$ 201
Debt instrument , Stated interest		9.875%
Percentage of Redemption of principal amount		104.938%

XML

Investments of Insurance Subsidiaries - Schedule of Investments (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Available For Sale Securities [Line Items]
Amortized Cost	$ 462	$ 552
Unrealized Amounts, Gains	13	24
Unrealized Amounts, Losses	(4)	(6)
Fair Value	471	570
Amounts classified as current assets	(66)	(55)
Investment carrying value	405	515
Auction Rate Securities [Member]
Available For Sale Securities [Line Items]
Fair Value	45
Debt Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	460	550
Unrealized Amounts, Gains	12	23
Unrealized Amounts, Losses	(4)	(6)
Fair Value	468	567
Debt Securities [Member] | States and Municipalities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	384	395
Unrealized Amounts, Gains	12	23
Unrealized Amounts, Losses	(2)
Fair Value	394	418
Debt Securities [Member] | Auction Rate Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	47	74
Unrealized Amounts, Gains
Unrealized Amounts, Losses	(2)	(6)
Fair Value	45	68
Debt Securities [Member] | Asset-Backed Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	12	14
Unrealized Amounts, Gains
Unrealized Amounts, Losses
Fair Value	12	14
Debt Securities [Member] | Money Market Funds [Member]
Available For Sale Securities [Line Items]
Amortized Cost	17	67
Unrealized Amounts, Gains
Unrealized Amounts, Losses
Fair Value	17	67
Equity Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	2	2
Unrealized Amounts, Gains	1	1
Unrealized Amounts, Losses
Fair Value	$ 3	$ 3

XML

Financial Instruments - Effect of Interest Rate and Cross Currency Swaps on Results of Operations (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Cross Currency Swap (Income Taxes and Other Liabilities) [Member] | Other Operating Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in Operations on Derivatives	$ 4
Interest Rate Swaps [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain Recognized in OCI on Derivatives, Net of Tax	25
Interest Rate Swaps [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Reclassified from Accumulated OCI into Operations	$ 64

XML

Capital Structure - Components of Accumulated Other Comprehensive Loss (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss [Abstract]
Unrealized gains on available-for-sale securities, beginning balance	$ 11
Unrealized losses on available-for-sale securities, net of income taxes	(5)
Unrealized gains on available-for-sale securities, ending balance	6
Foreign currency translation adjustments, beginning balance	(1)
Foreign currency translation adjustments	(39)
Foreign currency translation adjustments, ending balance	(40)
Defined benefit plans, beginning balance	(196)
Defined benefit plans, expense reclassified into operations from other comprehensive income	9
Defined benefit plans, ending balance	(187)
Change in fair value of derivative instruments, beginning balance	(271)
Change in fair value of derivative instruments	25
Change in fair value of derivative instruments, expense reclassified into operations from other comprehensive income	41
Balances at June 30, 2013	(205)
Accumulated other comprehensive income, net of tax, beginning balance	(457)
Unrealized losses on available-for-sale securities, net of income taxes	(5)
Foreign currency translation adjustments, net of income tax benefit	(39)
Change in fair value of derivative instruments, net of income tax benefit	25
Expense reclassified into operations from other comprehensive income, Total	50
Accumulated other comprehensive income, net of tax, Ending balance	$ (426)

XML

Acquisitions and Dispositions - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Other Healthcare Entity [Member]
Business Acquisition [Line Items]
Cash paid for acquisition	$ 23	$ 81
Hospitals [Member]
Business Acquisition [Line Items]
Cash paid for acquisition		58
Liability assumed on acquisition		33
Goodwill recorded on acquisition		53
Pretax loss on sales of business	12
Proceeds from sale of business	31
Real Estate [Member]
Business Acquisition [Line Items]
Pretax loss on sales of business		3
Proceeds from sale of business		$ 6

XML

Assets and Liabilities Measured at Fair Value - Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Fair Value Disclosures [Abstract]
Asset, Beginning Balance	$ 70
Unrealized gains included in other comprehensive income	3
Settlements	(27)
Asset, Ending Balance	$ 46

XML

Long-Term Debt (Tables)

6 Months Ended

Jun. 30, 2013

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

A summary of long-term debt at June 30, 2013 and December 31, 2012, including related interest rates at June 30, 2013, follows (dollars in millions):

	June 30, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	1,450	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.1%)		5,939		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,691		9,688
Other senior secured debt (effective interest rate of 7.0%)		426		423
First lien debt		17,506		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,694		11,194
Total debt (average life of 6.7 years, rates averaging 6.4%)		28,200		28,930
Less amounts due within one year		1,456		1,435
	$	26,744	$	27,495

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 975	$ 1,124
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities	(2,335)	(1,927)
Provision for doubtful accounts	1,777	1,835
Depreciation and amortization	849	837
Income taxes	183	326
Losses on sales of facilities	12	3
Loss on retirement of debt	17
Amortization of deferred loan costs	28	29
Share-based compensation	51	23
Other	(3)	7
Net cash provided by operating activities	1,554	2,257
Cash flows from investing activities:
Purchase of property and equipment	(896)	(784)
Acquisition of hospitals and health care entities	(23)	(139)
Disposition of hospitals and health care entities	31	6
Change in investments	102	35
Other	(4)	(4)
Net cash used in investing activities	(790)	(886)
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving credit facilities	(20)	(820)
Repayment of long-term debt	(768)	(608)
Distributions to noncontrolling interests	(196)	(191)
Payment of debt issuance costs	(5)	(19)
Distributions to stockholders	(10)	(982)
Income tax benefits	61	71
Other	(69)	(27)
Net cash used in financing activities	(1,007)	(1,226)
Change in cash and cash equivalents	(243)	145
Cash and cash equivalents at beginning of period	705	373
Cash and cash equivalents at end of period	462	518
Interest payments	909	854
Income tax payments, net	$ 226	$ 141

XML

Acquisitions and Dispositions

6 Months Ended

Jun. 30, 2013

Business Combinations [Abstract]

Acquisitions and Dispositions

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

During the six months ended June 30, 2013 and 2012, we paid $23 million and $81 million, respectively, to acquire nonhospital health care entities. During the six months ended June 30, 2012, we paid $58 million, assumed liabilities of $33 million and recorded goodwill of $53 million related to the acquisition of a hospital facility in the American Group.

During the six months ended June 30, 2013, we received proceeds of $31 million and recognized net pretax losses of $12 million related to the sale of a hospital facility and other real estate investments. During the six months ended June 30, 2012, we received proceeds of $6 million and recognized net pretax losses of $3 million related to sales of real estate investments.

XML

Investments of Insurance Subsidiaries

6 Months Ended

Jun. 30, 2013

Investments Debt And Equity Securities [Abstract]

Investments of Insurance Subsidiaries

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES

A summary of our insurance subsidiaries’ investments at June 30, 2013 and December 31, 2012 follows (dollars in millions):

	June 30, 2013
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	384	$	12	$	(2	)	$	394
Auction rate securities		47		—		(2	)		45
Asset-backed securities		12		—		—			12
Money market funds		17		—		—			17
		460		12		(4	)		468
Equity securities		2		1		—			3
	$	462	$	13	$	(4	)		471
Amounts classified as current assets									(66	)
Investment carrying value								$	405

	December 31, 2012
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—		$	418
Auction rate securities		74		—		(6	)		68
Asset-backed securities		14		—		—			14
Money market funds		67		—		—			67
		550		23		(6	)		567
Equity securities		2		1		—			3
	$	552	$	24	$	(6	)		570
Amounts classified as current assets									(55	)
Investment carrying value								$	515

At June 30, 2013 and December 31, 2012, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. At June 30, 2013 and December 31, 2012, $1 million and $9 million, respectively, of our money market fund investments were subject to restrictions included in insurance bond collateralization and assumed reinsurance contracts.

Scheduled maturities of investments in debt securities at June 30, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	31	$	31
Due after one year through five years		174		180
Due after five years through ten years		103		106
Due after ten years		93		94
		401		411
Auction rate securities		47		45
Asset-backed securities		12		12
	$	460	$	468

The average expected maturity of the investments in debt securities at June 30, 2013 was 4.4 years, compared to the average scheduled maturity of 7.7 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to the scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. At June 30, 2013, the average expected maturities for our auction rate and asset-backed securities were 3.9 years and 3.7 years, respectively, compared to average scheduled maturities of 21.5 years and 23.5 years, respectively.

XML

Income Taxes

6 Months Ended

Jun. 30, 2013

Income Tax Disclosure [Abstract]

Income Taxes

NOTE 3 — INCOME TAXES

During the six months ended June 30, 2013, we finalized settlements with the IRS resolving all outstanding issues for HCA Inc.’s 2007, 2008 and 2009 tax years. We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2010 and 2011 federal income tax returns in 2013.

Our liability for unrecognized tax benefits was $408 million, including accrued interest of $18 million, as of June 30, 2013 ($426 million and $14 million, respectively, as of December 31, 2012). Unrecognized tax benefits of $134 million ($125 million as of December 31, 2012) would affect the effective rate, if recognized. The provision for income taxes reflects $3 million ($2 million, net of tax) of interest expense and $18 million ($11 million, net of tax) of reductions in interest expense related to taxing authority examinations for the quarters ended June 30, 2013 and 2012, respectively, and $15 million and $21 million ($9 million and $13 million, respectively, net of tax) of reductions in interest expense related to taxing authority examinations for the six months ended June 30, 2013 and 2012, respectively.

Depending on the completion of examinations by federal, state or international taxing authorities, the resolution of any tax disputes, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

XML

Assets and Liabilities Measured at Fair Value - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Insurance subsidiaries investments, Fair Value	$ 471	$ 570
Investments in tax-exempt ARS at par value	460
Estimated fair value of long-term debt	28,061	30,781
Carrying amounts of long-term debt	28,200	28,930
Auction Rate Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Insurance subsidiaries investments, Fair Value	45
Investments in tax-exempt ARS at par value	47
Redeemed or repurchased of ARS at par value	$ 27	$ 65

XML

Supplemental Condensed Consolidating Financial Information (Tables)

6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Schedule of Condensed Consolidating Comprehensive Income Statement

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	5,012		$	4,461		$	—		$	9,473
Provision for doubtful accounts		—			—			608			415			—			1,023
Revenues		—			—			4,404			4,046			—			8,450
Salaries and benefits		—			—			2,058			1,790			—			3,848
Supplies		—			—			776			694			—			1,470
Other operating expenses		1			—			757			749			—			1,507
Electronic health record incentive income		—			—			(33	)		(19	)		—			(52	)
Equity in earnings of affiliates		(504	)		—			(1	)		(11	)		504			(12	)
Depreciation and amortization		—			—			211			214			—			425
Interest expense		51			544			(109	)		(24	)		—			462
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Management fees		—			—			(181	)		181			—			—
		(452	)		544			3,481			3,567			504			7,644
Income (loss) before income taxes		452			(544	)		923			479			(504	)		806
Provision (benefit) for income taxes		(20	)		(213	)		354			148			—			269
Net income (loss)		472			(331	)		569			331			(504	)		537
Net income attributable to noncontrolling interests		—			—			16			98			—			114
Net income (loss) attributable to HCA Holdings, Inc.	$	472		$	(331	)	$	553		$	233		$	(504	)	$	423
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	472		$	(283	)	$	558		$	229		$	(504	)	$	472

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,753		$	4,400		$	—		$	9,153
Provision for doubtful accounts		—			—			558			483			—			1,041
Revenues		—			—			4,195			3,917			—			8,112
Salaries and benefits		—			—			1,951			1,756			—			3,707
Supplies		—			—			738			684			—			1,422
Other operating expenses		—			—			751			742			—			1,493
Electronic health record incentive income		—			—			(48	)		(22	)		—			(70	)
Equity in earnings of affiliates		(409	)		—			(1	)		(8	)		409			(9	)
Depreciation and amortization		—			—			209			211			—			420
Interest expense		30			529			(85	)		(26	)		—			448
Losses on sales of facilities		—			—			2			—			—			2
Management fees		—			—			(168	)		168			—			—
		(379	)		529			3,349			3,505			409			7,413
Income (loss) before income taxes		379			(529	)		846			412			(409	)		699
Provision (benefit) for income taxes		(12	)		(189	)		297			118			—			214
Net income (loss)		391			(340	)		549			294			(409	)		485
Net income attributable to noncontrolling interests		—			—			16			78			—			94
Net income (loss) attributable to HCA Holdings, Inc.	$	391		$	(340	)	$	533		$	216		$	(409	)	$	391
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	391		$	(369	)	$	538		$	202		$	(409	)	$	353

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	9,884		$	8,783		$	—		$	18,667
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Revenues		—			—			8,833			8,057			—			16,890
Salaries and benefits		—			—			4,185			3,580			—			7,765
Supplies		—			—			1,567			1,382			—			2,949
Other operating expenses		2			—			1,489			1,539			—			3,030
Electronic health record incentive income		—			—			(62	)		(29	)		—			(91	)
Equity in earnings of affiliates		(860	)		—			(2	)		(18	)		860			(20	)
Depreciation and amortization		—			—			420			429			—			849
Interest expense		97			1,102			(215	)		(50	)		—			934
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(364	)		364			—			—
		(761	)		1,119			7,037			7,190			860			15,445
Income (loss) before income taxes		761			(1,119	)		1,796			867			(860	)		1,445
Provision (benefit) for income taxes		(37	)		(425	)		671			261			—			470
Net income (loss)		798			(694	)		1,125			606			(860	)		975
Net income attributable to noncontrolling interests		—			—			29			179			—			208
Net income (loss) attributable to HCA Holdings, Inc.	$	798		$	(694	)	$	1,096		$	427		$	(860	)	$	767
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	798		$	(630	)	$	1,105		$	385		$	(860	)	$	798

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	9,656		$	8,696		$	—		$	18,352
Provision for doubtful accounts		—			—			1,021			814			—			1,835
Revenues		—			—			8,635			7,882			—			16,517
Salaries and benefits		—			—			3,933			3,510			—			7,443
Supplies		—			—			1,491			1,350			—			2,841
Other operating expenses		—			4			1,480			1,502			—			2,986
Electronic health record incentive income		—			—			(89	)		(36	)		—			(125	)
Equity in earnings of affiliates		(969	)		—			(3	)		(17	)		969			(20	)
Depreciation and amortization		—			—			409			428			—			837
Interest expense		60			1,058			(176	)		(52	)		—			890
Losses on sales of facilities		—			—			3			—			—			3
Management fees		—			—			(328	)		328			—			—
		(909	)		1,062			6,720			7,013			969			14,855
Income (loss) before income taxes		909			(1,062	)		1,915			869			(969	)		1,662
Provision (benefit) for income taxes		(22	)		(389	)		689			260			—			538
Net income (loss)		931			(673	)		1,226			609			(969	)		1,124
Net income attributable to noncontrolling interests		—			—			33			160			—			193
Net income (loss) attributable to HCA Holdings, Inc.	$	931		$	(673	)	$	1,193		$	449		$	(969	)	$	931
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	931		$	(698	)	$	1,202		$	456		$	(969	)	$	922

Schedule of Condensed Consolidating Balance Sheet

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	152		$	310	$	—		$	462
Accounts receivable, net		—			—			2,492			2,423		—			4,915
Inventories		—			—			683			469		—			1,152
Deferred income taxes		401			—			—			—		—			401
Other		—			—			309			552		—			861
		401			—			3,636			3,754		—			7,791
Property and equipment, net		—			—			7,432			5,797		—			13,229
Investments of insurance subsidiaries		—			—			—			405		—			405
Investments in and advances to affiliates		19,341			—			15			105		(19,341	)		120
Goodwill and other intangible assets		—			—			1,695			3,839		—			5,534
Deferred loan costs		31			233			—			—		—			264
Other		362			—			26			203		—			591
	$	20,135		$	233		$	12,804		$	14,103	$	(19,341	)	$	27,934
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,090		$	567	$	—		$	1,657
Accrued salaries		—			—			601			435		—			1,036
Other accrued expenses		261			375			460			775		—			1,871
Long-term debt due within one year		—			1,381			43			32		—			1,456
		261			1,756			2,194			1,809		—			6,020
Long-term debt		2,525			23,555			174			490		—			26,744
Intercompany balances		25,729			(10,782	)		(18,290	)		3,343		—			—
Professional liability risks		—			—			—			960		—			960
Income taxes and other liabilities		443			342			674			236		—			1,695
		28,958			14,871			(15,248	)		6,838		—			35,419
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,823	)		(14,638	)		27,952			6,027		(19,341	)		(8,823	)
Noncontrolling interests		—			—			100			1,238		—			1,338
		(8,823	)		(14,638	)		28,052			7,265		(19,341	)		(7,485	)
	$	20,135		$	233		$	12,804		$	14,103	$	(19,341	)	$	27,934

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

Schedule of Condensed Consolidating Statement of Cash Flows

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	798		$	(694	)	$	1,125		$	606		$	(860	)	$	975
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		41			(18	)		(1,217	)		(1,141	)		—			(2,335	)
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Depreciation and amortization		—			—			420			429			—			849
Income taxes		183			—			—			—			—			183
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		2			26			—			—			—			28
Share-based compensation		51			—			—			—			—			51
Equity in earnings of affiliates		(860	)		—			—			—			860			—
Other		—			4			—			(7	)		—			(3	)
Net cash provided by (used in) operating activities		215			(665	)		1,398			606			—			1,554
Cash flows from investing activities:
Purchase of property and equipment		—			—			(434	)		(462	)		—			(896	)
Acquisition of hospitals and health care entities		—			—			—			(23	)		—			(23	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			5			97			—			102
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(413	)		(377	)		—			(790	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			(20	)		—			—			—			(20	)
Repayment of long-term debt		—			(726	)		(22	)		(20	)		—			(768	)
Distributions to noncontrolling interests		—			—			(29	)		(167	)		—			(196	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(216	)		1,416			(1,165	)		(35	)		—			—
Income tax benefits		61			—			—			—			—			61
Other		(72	)		—			—			3			—			(69	)
Net cash (used in) provided by financing activities		(237	)		665			(1,216	)		(219	)		—			(1,007	)
Change in cash and cash equivalents		(22	)		—			(231	)		10			—			(243	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	152		$	310		$	—		$	462

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	931		$	(673	)	$	1,226		$	609		$	(969	)	$	1,124
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		—			12			(995	)		(944	)		—			(1,927	)
Provision for doubtful accounts		—			—			1,021			814			—			1,835
Depreciation and amortization		—			—			409			428			—			837
Income taxes		326			—			—			—			—			326
Losses on sales of facilities		—			—			3			—			—			3
Amortization of deferred loan costs		1			28			—			—			—			29
Share-based compensation		23			—			—			—			—			23
Equity in earnings of affiliates		(969	)		—			—			—			969			—
Other		—			8			(1	)		—			—			7
Net cash provided by (used in) operating activities		312			(625	)		1,663			907			—			2,257
Cash flows from investing activities:
Purchase of property and equipment		—			—			(408	)		(376	)		—			(784	)
Acquisition of hospitals and health care entities		—			—			(72	)		(67	)		—			(139	)
Disposition of hospitals and health care entities		—			—			1			5			—			6
Change in investments		—			—			(8	)		43			—			35
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(488	)		(398	)		—			(886	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(820	)		—			—			—			(820	)
Repayment of long-term debt		—			(545	)		(16	)		(47	)		—			(608	)
Distributions to noncontrolling interests		—			—			(36	)		(155	)		—			(191	)
Payment of debt issuance costs		—			(19	)		—			—			—			(19	)
Distributions to stockholders		(982	)		—			—			—			—			(982	)
Changes in intercompany balances with affiliates, net		628			659			(1,115	)		(172	)		—			—
Income tax benefits		71			—			—			—			—			71
Other		(29	)		—			—			2			—			(27	)
Net cash (used in) provided by financing activities		(312	)		625			(1,167	)		(372	)		—			(1,226	)
Change in cash and cash equivalents		—			—			8			137			—			145
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	123		$	395		$	—		$	518

XML

Income Taxes - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2012	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Liability for unrecognized tax benefits	$ 408			$ 426
Unrecognized tax benefits, accrued interest	18			14
Unrecognized tax benefits that would impact effective tax rate	134			125
Reductions in interest related to taxing authority examinations	3	18	21
Reductions in interest related to taxing authority examinations net of tax	$ 2	$ 11	$ 13

XML

Financial Instruments - Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) (Pay-Fixed Interest Rate Swaps [Member], USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Maturity Date, 2014 [Member]
Derivative Instruments [Line Items]
Fair Value	$ (7)
Pay-fixed interest rate swaps	Dec. 31, 2014
Notional Amount	500
Maturity Date, 2016 [Member]
Derivative Instruments [Line Items]
Fair Value	(273)
Pay-fixed interest rate swaps	Dec. 31, 2016
Notional Amount	3,000
Maturity Date, 2017 [Member]
Derivative Instruments [Line Items]
Fair Value	(45)
Pay-fixed interest rate swaps	Dec. 31, 2017
Notional Amount	$ 1,000

XML

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Balance Sheet (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 462	$ 705	$ 518	$ 373
Accounts receivable, net	4,915	4,672
Inventories	1,152	1,086
Deferred income taxes	401	385
Other	861	915
Total current assets	7,791	7,763
Property and equipment, net	13,229	13,185
Investments of insurance subsidiaries	405	515
Investments in and advances to affiliates	120	104
Goodwill and other intangible assets	5,534	5,539
Deferred loan costs	264	290
Other	591	679
Total assets	27,934	28,075
Current liabilities:
Accounts payable	1,657	1,768
Accrued salaries	1,036	1,120
Other accrued expenses	1,871	1,849
Long-term debt due within one year	1,456	1,435
Total current liabilities	6,020	6,172
Long-term debt	26,744	27,495
Intercompany balances
Professional liability risks	960	973
Income taxes and other liabilities	1,695	1,776
Total liabilities	35,419	36,416
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(8,823)	(9,660)
Noncontrolling interests	1,338	1,319
Total stockholders' deficit	(7,485)	(8,341)
Total liabilities and stockholders' deficit	27,934	28,075
HCA Holdings, Inc. Issuer [Member]
Current assets:
Cash and cash equivalents		22
Accounts receivable, net
Inventories
Deferred income taxes	401	385
Other		122
Total current assets	401	529
Property and equipment, net
Investments of insurance subsidiaries
Investments in and advances to affiliates	19,341	18,481
Goodwill and other intangible assets
Deferred loan costs	31	32
Other	362	469
Total assets	20,135	19,511
Current liabilities:
Accounts payable
Accrued salaries
Other accrued expenses	261	30
Long-term debt due within one year
Total current liabilities	261	30
Long-term debt	2,525	2,525
Intercompany balances	25,729	26,131
Professional liability risks
Income taxes and other liabilities	443	485
Total liabilities	28,958	29,171
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(8,823)	(9,660)
Noncontrolling interests
Total stockholders' deficit	(8,823)	(9,660)
Total liabilities and stockholders' deficit	20,135	19,511
HCA Inc. Issuer [Member]
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories
Deferred income taxes
Other
Total current assets
Property and equipment, net
Investments of insurance subsidiaries
Investments in and advances to affiliates
Goodwill and other intangible assets
Deferred loan costs	233	258
Other
Total assets	233	258
Current liabilities:
Accounts payable
Accrued salaries
Other accrued expenses	375	567
Long-term debt due within one year	1,381	1,360
Total current liabilities	1,756	1,927
Long-term debt	23,555	24,304
Intercompany balances	(10,782)	(12,407)
Professional liability risks
Income taxes and other liabilities	342	442
Total liabilities	14,871	14,266
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(14,638)	(14,008)
Noncontrolling interests
Total stockholders' deficit	(14,638)	(14,008)
Total liabilities and stockholders' deficit	233	258
Subsidiary Guarantors [Member]
Current assets:
Cash and cash equivalents	152	383	123	115
Accounts receivable, net	2,492	2,448
Inventories	683	629
Deferred income taxes
Other	309	342
Total current assets	3,636	3,802
Property and equipment, net	7,432	7,417
Investments of insurance subsidiaries
Investments in and advances to affiliates	15	16
Goodwill and other intangible assets	1,695	1,697
Deferred loan costs
Other	26	31
Total assets	12,804	12,963
Current liabilities:
Accounts payable	1,090	1,203
Accrued salaries	601	638
Other accrued expenses	460	464
Long-term debt due within one year	43	39
Total current liabilities	2,194	2,344
Long-term debt	174	173
Intercompany balances	(18,290)	(17,130)
Professional liability risks
Income taxes and other liabilities	674	629
Total liabilities	(15,248)	(13,984)
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	27,952	26,847
Noncontrolling interests	100	100
Total stockholders' deficit	28,052	26,947
Total liabilities and stockholders' deficit	12,804	12,963
Subsidiary Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	310	300	395	258
Accounts receivable, net	2,423	2,224
Inventories	469	457
Deferred income taxes
Other	552	451
Total current assets	3,754	3,432
Property and equipment, net	5,797	5,768
Investments of insurance subsidiaries	405	515
Investments in and advances to affiliates	105	88
Goodwill and other intangible assets	3,839	3,842
Deferred loan costs
Other	203	179
Total assets	14,103	13,824
Current liabilities:
Accounts payable	567	565
Accrued salaries	435	482
Other accrued expenses	775	788
Long-term debt due within one year	32	36
Total current liabilities	1,809	1,871
Long-term debt	490	493
Intercompany balances	3,343	3,406
Professional liability risks	960	973
Income taxes and other liabilities	236	220
Total liabilities	6,838	6,963
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	6,027	5,642
Noncontrolling interests	1,238	1,219
Total stockholders' deficit	7,265	6,861
Total liabilities and stockholders' deficit	14,103	13,824
Eliminations [Member]
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories
Deferred income taxes
Other
Total current assets
Property and equipment, net
Investments of insurance subsidiaries
Investments in and advances to affiliates	(19,341)	(18,481)
Goodwill and other intangible assets
Deferred loan costs
Other
Total assets	(19,341)	(18,481)
Current liabilities:
Accounts payable
Accrued salaries
Other accrued expenses
Long-term debt due within one year
Total current liabilities
Long-term debt
Intercompany balances
Professional liability risks
Income taxes and other liabilities
Total liabilities
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(19,341)	(18,481)
Noncontrolling interests
Total stockholders' deficit	(19,341)	(18,481)
Total liabilities and stockholders' deficit	$ (19,341)	$ (18,481)

XML

Capital Structure - Components of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Amounts Reclassified Out Of Accumulated Other Comprehensive Income Loss [Abstract]
Unrealized losses on available-for-Sale Securities, Tax portion	$ 3
Foreign currency translation adjustments, income (taxes)	21
Change in fair value of derivative instruments, income tax benefit	15
Defined benefit plan, (income) expense reclassified into operations from other comprehensive income, Tax portion	6
Change in fair value of derivative instruments, (income) expense reclassified into other comprehensive income, Tax Portion	$ 23

XML

Long-Term Debt - Schedule of Long-Term Debt (Parenthetical) (Detail)	Jun. 30, 2013
Debt Instrument [Line Items]
Total debt average term	6 years 8 months 12 days
Total debt average rate	6.40%
Senior Secured Asset-Based Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Effective interest rate	1.70%
Senior Secured Term Loan Facilities [Member]
Debt Instrument [Line Items]
Effective interest rate	5.10%
Senior Secured First Lien Notes [Member]
Debt Instrument [Line Items]
Effective interest rate	7.10%
Other Senior Secured Debt [Member]
Debt Instrument [Line Items]
Effective interest rate	7.00%
Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Effective interest rate	7.20%

XML

Condensed Consolidated Comprehensive Income Statements (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 537	$ 485	$ 975	$ 1,124
Other comprehensive income (loss) before taxes:
Foreign currency translation		(22)	(60)	7
Unrealized (losses) gains on available-for-sale securities	(9)		(8)	5
Defined benefit plans
Pension costs included in salaries and benefits	8	7	15	14
Total defined benefit plans	8	7	15	14
Change in fair value of derivative financial instruments	47	(77)	40	(102)
Interest costs included in interest expense	32	31	64	60
Total change in fair value of derivative financial instruments	79	(46)	104	(42)
Other comprehensive income (loss) before taxes	78	(61)	51	(16)
Income taxes (benefits) related to other comprehensive income items	29	(23)	20	(7)
Other comprehensive income (loss)	49	(38)	31	(9)
Comprehensive income	586	447	1,006	1,115
Comprehensive income attributable to noncontrolling interests	114	94	208	193
Comprehensive income attributable to HCA Holdings, Inc.	$ 472	$ 353	$ 798	$ 922

XML

Long-Term Debt

6 Months Ended

Jun. 30, 2013

Debt Disclosure [Abstract]

Long-Term Debt

NOTE 8 — LONG-TERM DEBT

A summary of long-term debt at June 30, 2013 and December 31, 2012, including related interest rates at June 30, 2013, follows (dollars in millions):

	June 30, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	1,450	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.1%)		5,939		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,691		9,688
Other senior secured debt (effective interest rate of 7.0%)		426		423
First lien debt		17,506		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,694		11,194
Total debt (average life of 6.7 years, rates averaging 6.4%)		28,200		28,930
Less amounts due within one year		1,456		1,435
	$	26,744	$	27,495

2013 Activity

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 7/8% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Millions, except Share data, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]
Allowance for Accounts receivable	$ 4,965	$ 4,846
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, shares outstanding	447,066,900	443,200,200

XML

Condensed Consolidated Income Statements (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Statement [Abstract]
Revenues before provision for doubtful accounts	$ 9,473	$ 9,153	$ 18,667	$ 18,352
Provision for doubtful accounts	1,023	1,041	1,777	1,835
Revenues	8,450	8,112	16,890	16,517
Salaries and benefits	3,848	3,707	7,765	7,443
Supplies	1,470	1,422	2,949	2,841
Other operating expenses	1,507	1,493	3,030	2,986
Electronic health record incentive income	(52)	(70)	(91)	(125)
Equity in earnings of affiliates	(12)	(9)	(20)	(20)
Depreciation and amortization	425	420	849	837
Interest expense	462	448	934	890
Losses (gains) on sales of facilities	(4)	2	12	3
Loss on retirement of debt			17
Total expenses including equity in earnings of a affiliates	7,644	7,413	15,445	14,855
Income before income taxes	806	699	1,445	1,662
Provision for income taxes	269	214	470	538
Net income	537	485	975	1,124
Net income attributable to noncontrolling interests	114	94	208	193
Net income attributable to HCA Holdings, Inc.	$ 423	$ 391	$ 767	$ 931
Per share data:
Basic earnings per share	$ 0.95	$ 0.89	$ 1.72	$ 2.12
Diluted earnings per share	$ 0.91	$ 0.85	$ 1.66	$ 2.03
Cash dividends declared per share				$ 2.00
Shares used in earnings per share calculations (in thousands):
Basic	446,612	439,473	445,513	438,705
Diluted	463,184	458,621	462,782	458,467

XML

Segment and Geographic Information - Additional Information (Detail)	Jun. 30, 2013 Hospital
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	161
Reorganization Group [Member]
Segment Reporting Information [Line Items]
Number of geographically organized groups	2
Reorganization Group [Member] | National Group [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	77
Reorganization Group [Member] | American Group [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	78
Reorganization Group [Member] | Corporate and Other [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	6

XML

Interim Condensed Consolidated Financial Statements - Additional Information (Detail) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2013 Hospital	Jun. 30, 2012	Mar. 31, 2011	Jun. 30, 2013 Surgery_Center State Hospital	Jun. 30, 2012
Summary Of Significant Accounting Policies [Line Items]
Initial public offering of shares common stock			87,719,300
Number of owned and operated hospitals	161			161
Number of freestanding surgery centers				114
Number of facilities locations				20
General and administrative expense	$ 65	$ 59		$ 131	$ 112
Adjustments to Medicare revenues					188
Adjustment and related expenses added to income before income taxes					170
Adjustment and related expenses added to income before income taxes in diluted per share					$ 0.22
Rural Floor Provision Settlement Effect [Member]
Summary Of Significant Accounting Policies [Line Items]
Adjustments to Medicare revenues					271
Implementation of Revised Supplemental Security Income Ratios [Member]
Summary Of Significant Accounting Policies [Line Items]
Adjustments to Medicare revenues					$ 83

XML

Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2013

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at June 30, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(7	)
Pay-fixed interest rate swaps		3,000		December 2016		(273	)
Pay-fixed interest rate swaps		1,000		December 2017		(45	)

Schedule of Cross Currency Swap Agreement Not Designated as Hedge

Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at June 30, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(17	)

Effect of Interest Rate and Cross Currency Swaps on Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the six months ended June 30, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Gain Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	25		Interest expense	$	64

Derivatives Not Designated as Hedging Instruments	Location of Loss Recognized in Operations on Derivatives		Amount of Loss Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	4

XML

Long-Term Debt - Schedule of Long-Term Debt (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
First lien debt	$ 17,506	$ 17,539
Total debt	28,200	28,930
Less amounts due within one year	1,456	1,435
Long-term debt	26,744	27,495
Senior Secured Asset-Based Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit	1,450	1,470
Senior Secured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit
Senior Secured Term Loan Facilities [Member]
Debt Instrument [Line Items]
Term loans	5,939	5,958
Senior Secured First Lien Notes [Member]
Debt Instrument [Line Items]
Senior secured first lien notes	9,691	9,688
Other Senior Secured Debt [Member]
Debt Instrument [Line Items]
Other senior secured debt	426	423
Senior Secured Second Lien Notes [Member]
Debt Instrument [Line Items]
Senior secured second lien notes		197
Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes	$ 10,694	$ 11,194

XML

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Comprehensive Income Statement (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2013	Mar. 31, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts	$ 9,473		$ 9,153	$ 18,667	$ 18,352
Provision for doubtful accounts	1,023		1,041	1,777	1,835
Revenues	8,450		8,112	16,890	16,517
Salaries and benefits	3,848		3,707	7,765	7,443
Supplies	1,470		1,422	2,949	2,841
Other operating expenses	1,507		1,493	3,030	2,986
Electronic health record incentive income	(52)		(70)	(91)	(125)
Equity in earnings of affiliates	(12)		(9)	(20)	(20)
Depreciation and amortization	425		420	849	837
Interest expense	462		448	934	890
Losses (gains) on sales of facilities	(4)		2	12	3
Loss on retirement of debt		(17)		17
Management fees
Total expenses including equity in earnings of a affiliates	7,644		7,413	15,445	14,855
Income (loss) before income taxes	806		699	1,445	1,662
Provision (benefit) for income taxes	269		214	470	538
Net income (loss)	537		485	975	1,124
Net income attributable to noncontrolling interests	114		94	208	193
Net income attributable to HCA Holdings, Inc.	423		391	767	931
Comprehensive income (loss) attributable to HCA Holdings, Inc.	472		353	798	922
HCA Holdings, Inc. Issuer [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses	1			2
Electronic health record incentive income
Equity in earnings of affiliates	(504)		(409)	(860)	(969)
Depreciation and amortization
Interest expense	51		30	97	60
Losses (gains) on sales of facilities
Loss on retirement of debt
Management fees
Total expenses including equity in earnings of a affiliates	(452)		(379)	(761)	(909)
Income (loss) before income taxes	452		379	761	909
Provision (benefit) for income taxes	(20)		(12)	(37)	(22)
Net income (loss)	472		391	798	931
Net income attributable to noncontrolling interests
Net income attributable to HCA Holdings, Inc.	472		391	798	931
Comprehensive income (loss) attributable to HCA Holdings, Inc.	472		391	798	931
HCA Inc. Issuer [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses					4
Electronic health record incentive income
Equity in earnings of affiliates
Depreciation and amortization
Interest expense	544		529	1,102	1,058
Losses (gains) on sales of facilities
Loss on retirement of debt				17
Management fees
Total expenses including equity in earnings of a affiliates	544		529	1,119	1,062
Income (loss) before income taxes	(544)		(529)	(1,119)	(1,062)
Provision (benefit) for income taxes	(213)		(189)	(425)	(389)
Net income (loss)	(331)		(340)	(694)	(673)
Net income attributable to noncontrolling interests
Net income attributable to HCA Holdings, Inc.	(331)		(340)	(694)	(673)
Comprehensive income (loss) attributable to HCA Holdings, Inc.	(283)		(369)	(630)	(698)
Subsidiary Guarantors [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts	5,012		4,753	9,884	9,656
Provision for doubtful accounts	608		558	1,051	1,021
Revenues	4,404		4,195	8,833	8,635
Salaries and benefits	2,058		1,951	4,185	3,933
Supplies	776		738	1,567	1,491
Other operating expenses	757		751	1,489	1,480
Electronic health record incentive income	(33)		(48)	(62)	(89)
Equity in earnings of affiliates	(1)		(1)	(2)	(3)
Depreciation and amortization	211		209	420	409
Interest expense	(109)		(85)	(215)	(176)
Losses (gains) on sales of facilities	3		2	19	3
Loss on retirement of debt
Management fees	(181)		(168)	(364)	(328)
Total expenses including equity in earnings of a affiliates	3,481		3,349	7,037	6,720
Income (loss) before income taxes	923		846	1,796	1,915
Provision (benefit) for income taxes	354		297	671	689
Net income (loss)	569		549	1,125	1,226
Net income attributable to noncontrolling interests	16		16	29	33
Net income attributable to HCA Holdings, Inc.	553		533	1,096	1,193
Comprehensive income (loss) attributable to HCA Holdings, Inc.	558		538	1,105	1,202
Subsidiary Non-Guarantors [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts	4,461		4,400	8,783	8,696
Provision for doubtful accounts	415		483	726	814
Revenues	4,046		3,917	8,057	7,882
Salaries and benefits	1,790		1,756	3,580	3,510
Supplies	694		684	1,382	1,350
Other operating expenses	749		742	1,539	1,502
Electronic health record incentive income	(19)		(22)	(29)	(36)
Equity in earnings of affiliates	(11)		(8)	(18)	(17)
Depreciation and amortization	214		211	429	428
Interest expense	(24)		(26)	(50)	(52)
Losses (gains) on sales of facilities	(7)			(7)
Loss on retirement of debt
Management fees	181		168	364	328
Total expenses including equity in earnings of a affiliates	3,567		3,505	7,190	7,013
Income (loss) before income taxes	479		412	867	869
Provision (benefit) for income taxes	148		118	261	260
Net income (loss)	331		294	606	609
Net income attributable to noncontrolling interests	98		78	179	160
Net income attributable to HCA Holdings, Inc.	233		216	427	449
Comprehensive income (loss) attributable to HCA Holdings, Inc.	229		202	385	456
Eliminations [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses
Electronic health record incentive income
Equity in earnings of affiliates	504		409	860	969
Depreciation and amortization
Interest expense
Losses (gains) on sales of facilities
Loss on retirement of debt
Management fees
Total expenses including equity in earnings of a affiliates	504		409	860	969
Income (loss) before income taxes	(504)		(409)	(860)	(969)
Provision (benefit) for income taxes
Net income (loss)	(504)		(409)	(860)	(969)
Net income attributable to noncontrolling interests
Net income attributable to HCA Holdings, Inc.	(504)		(409)	(860)	(969)
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$ (504)		$ (409)	$ (860)	$ (969)

XML

Financial Instruments - Schedule of Cross Currency Swap Agreement Not Designated as Hedge (Detail) (Euro - United States Dollar Currency Swap [Member], Maturity Date, November 2013 [Member]) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013 USD ($)	Jun. 30, 2013 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value	$ (17)
Maturity Date	Nov. 30, 2013	Nov. 30, 2013
Notional amount for foreign currency derivatives		€ 241

XML

Investments of Insurance Subsidiaries - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investments subject to restrictions	$ 1	$ 9
Available for sale securities expected maturity of debt securities	4 years 4 months 24 days
Available for sale securities average scheduled maturity	7 years 8 months 12 days
Auction Rate Securities [Member]
Schedule of Trading Securities and Other Trading Assets [Line Items]
Available for sale securities expected maturity of debt securities	3 years 10 months 24 days
Available for sale securities average scheduled maturity	21 years 6 months
Asset-Backed Securities [Member]
Schedule of Trading Securities and Other Trading Assets [Line Items]
Available for sale securities expected maturity of debt securities	3 years 8 months 12 days
Available for sale securities average scheduled maturity	23 years 6 months

XML

Investments of Insurance Subsidiaries - Schedule of Maturities of Investments (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]
Due in one year or less, Amortized Cost	$ 31
Due after one year through five years, Amortized Cost	174
Due after five years through ten years, Amortized Cost	103
Due after ten years, Amortized Cost	93
Amortized Cost, Total	401
Amortized Cost	460
Due in one year or less, Fair Value	31
Fair Value	471	570
Due after one year through five years, Fair Value	180
Due after five years through ten years, Fair Value	106
Due after ten years, Fair Value	94
Fair Value, Total	411
Fair Value	468
Auction Rate Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	47
Fair Value	45
Asset-Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	12
Fair Value	$ 12

XML

Assets and Liabilities Measured at Fair Value

6 Months Ended

Jun. 30, 2013

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The transaction price is initially used as the best estimate of fair value.

Our wholly-owned insurance subsidiaries had investments in tax-exempt auction rate securities (“ARS”), which are backed by student loans substantially guaranteed by the federal government, of $45 million ($47 million par value) at June 30, 2013. We do not currently intend to attempt to sell the ARS as the liquidity needs of our insurance subsidiaries are expected to be met by other investments in their investment portfolios. During 2012 and the six months ended June 30, 2013, certain issuers and their broker/dealers redeemed or repurchased $65 million and $27 million, respectively, of our ARS at par value. The valuation of these securities involved management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived a fair market value compared to tax-equivalent yields of other student loan backed variable rate securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at June 30, 2013 and December 31, 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of June 30, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	June 30, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	394		$	—		$	394		$	—
Auction rate securities		45			—			—			45
Asset-backed securities		12			—			12			—
Money market funds		17			17			—			—
		468			17			406			45
Equity securities		3			2			—			1
Investments of insurance subsidiaries		471			19			406			46
Less amounts classified as current assets		(66	)		(17	)		(49	)		—
	$	405		$	2		$	357		$	46
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	17		$	—		$	17		$	—
Interest rate swaps (Income taxes and other liabilities)		325			—			325			—

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the six months ended June 30, 2013 (dollars in millions):

Asset balances at December 31, 2012	$	70
Unrealized gains included in other comprehensive income		3
Settlements		(27	)
Asset balances at June 30, 2013	$	46

The estimated fair value of our long-term debt was $28.061 billion and $30.781 billion at June 30, 2013 and December 31, 2012, respectively, compared to carrying amounts aggregating $28.200 billion and $28.930 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

XML

Interim Condensed Consolidated Financial Statements - Schedule of Revenues from Third Party Payers and Uninsured (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Revenues [Line Items]
Revenues from third party payers	$ 8,469	$ 8,195	$ 16,959	$ 16,735
Uninsured	693	739	1,092	1,181
Other	311	219	616	436
Revenues before provision for doubtful accounts	9,473	9,153	18,667	18,352
Provision for doubtful accounts	(1,023)	(1,041)	(1,777)	(1,835)
Revenues	8,450	8,112	16,890	16,517
Revenues from third party payers, ratio	100.20%	101.00%	100.40%	101.30%
Uninsured Ratio	8.20%	9.10%	6.50%	7.20%
Other Ratio	3.70%	2.70%	3.60%	2.60%
Revenues before provision for doubtful accounts, ratio	112.10%	112.80%	110.50%	111.10%
Provision for doubtful accounts Ratio	(12.10%)	(12.80%)	(10.50%)	(11.10%)
Revenues ratio from third party payers	100.00%	100.00%	100.00%	100.00%
Medicare [Member]
Revenues [Line Items]
Revenues from third party payers	1,976	1,989	4,114	4,302
Revenues from third party payers, ratio	23.40%	24.50%	24.40%	26.00%
Managed Medicare [Member]
Revenues [Line Items]
Revenues from third party payers	804	729	1,647	1,479
Revenues from third party payers, ratio	9.50%	9.00%	9.80%	9.00%
Medicaid [Member]
Revenues [Line Items]
Revenues from third party payers	365	380	697	810
Revenues from third party payers, ratio	4.30%	4.70%	4.10%	4.90%
Managed Medicaid [Member]
Revenues [Line Items]
Revenues from third party payers	378	358	779	700
Revenues from third party payers, ratio	4.50%	4.40%	4.60%	4.20%
Managed Care and Other Insurers [Member]
Revenues [Line Items]
Revenues from third party payers	4,655	4,473	9,141	8,918
Revenues from third party payers, ratio	55.10%	55.10%	54.10%	54.00%
International (Managed Care and Other Insurers) [Member]
Revenues [Line Items]
Revenues from third party payers	$ 291	$ 266	$ 581	$ 526
Revenues from third party payers, ratio	3.40%	3.30%	3.40%	3.20%

XML

Assets and Liabilities Measured at Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	$ 471	$ 570
Less amounts classified as current assets	(66)	(55)
Investments of insurance subsidiaries, noncurrent	405	515
Cross Currency Swap (Income Taxes and Other Liabilities) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	17	13
Interest Rate Swaps [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	325	429
Auction Rate Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	45
Equity Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	3	3
Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	468	567
Debt Securities [Member] | States and Municipalities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	394	418
Debt Securities [Member] | Auction Rate Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	45	68
Debt Securities [Member] | Asset-Backed Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	12	14
Debt Securities [Member] | Money Market Funds [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	17	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	19	68
Less amounts classified as current assets	(17)	(55)
Investments of insurance subsidiaries, noncurrent	2	13
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Equity Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	2	1
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	17	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | Money Market Funds [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	17	67
Significant Other Observable Inputs (Level 2) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	406	432
Less amounts classified as current assets	(49)
Investments of insurance subsidiaries, noncurrent	357	432
Significant Other Observable Inputs (Level 2) [Member] | Cross Currency Swap (Income Taxes and Other Liabilities) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	17	13
Significant Other Observable Inputs (Level 2) [Member] | Interest Rate Swaps [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	325	429
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	406	432
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | States and Municipalities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	394	418
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | Asset-Backed Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	12	14
Significant Unobservable Inputs (Level 3) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	46	70
Investments of insurance subsidiaries, noncurrent	46	70
Significant Unobservable Inputs (Level 3) [Member] | Equity Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	1	2
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	45	68
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | Auction Rate Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	$ 45	$ 68

XML

Capital Structure

6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Capital Structure

NOTE 10 — CAPITAL STRUCTURE

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		Par Value
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			767			208			975
Other comprehensive income		—		—		—			31			—			—			31
Distributions		—		—		—			—			—			(196	)		(196	)
Share-based benefit plans		3,867		—		41			—			—			—			41
Other		—		—		(2	)		—			—			7			5
Balances at June 30, 2013		447,067	$	4	$	1,792		$	(426	)	$	(10,193	)	$	1,338		$	(7,485	)

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities			Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11		$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(5	)		—			—			—			(5	)
Foreign currency translation adjustments, net of $21 income tax benefit		—			(39	)		—			—			(39	)
Change in fair value of derivative instruments, net of $15 of income taxes		—			—			—			25			25
Expense reclassified into operations from other comprehensive income, net of $6 and $23, respectively, income tax benefits		—			—			9			41			50
Balances at June 30, 2013	$	6		$	(40	)	$	(187	)	$	(205	)	$	(426	)

XML

Financial Instruments

6 Months Ended

Jun. 30, 2013

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Financial Instruments

NOTE 6 — FINANCIAL INSTRUMENTS

Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at June 30, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(7	)
Pay-fixed interest rate swaps		3,000		December 2016		(273	)
Pay-fixed interest rate swaps		1,000		December 2017		(45	)

During the next 12 months, we estimate $125 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at June 30, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(17	)

Derivatives — Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the six months ended June 30, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Gain Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	25		Interest expense	$	64

Derivatives Not Designated as Hedging Instruments	Location of Loss Recognized in Operations on Derivatives		Amount of Loss Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	4

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of June 30, 2013, we have not been required to post any collateral related to these agreements. If we had breached these provisions at June 30, 2013, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $358 million.

XML

Interim Condensed Consolidated Financial Statements

6 Months Ended

Jun. 30, 2013

Quarterly Financial Information Disclosure [Abstract]

Interim Condensed Consolidated Financial Statements

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Reporting Entity

On November 17, 2006, HCA Inc. was acquired by a private investor group, including affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners and HCA founder, Dr. Thomas F. Frist Jr. and by members of management and certain other investors. The transaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. As a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities Exchange Act of 1934.

During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock. Upon the completion of a secondary offering in February 2013, we no longer qualify as a “controlled company” under the applicable New York Stock Exchange (“NYSE”) listing standards and will be required to appoint a board of directors comprised of a majority of independent members within one year of such date. Our common stock is traded on the NYSE (symbol “HCA”).

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At June 30, 2013, these affiliates owned and operated 161 hospitals, 114 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $65 million and $59 million for the quarters ended June 30, 2013 and 2012, respectively, and $131 million and $112 million for the six months ended June 30, 2013 and 2012, respectively. Operating results for the quarter and the six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,976			23.4	%	$	1,989			24.5	%
Managed Medicare		804			9.5			729			9.0
Medicaid		365			4.3			380			4.7
Managed Medicaid		378			4.5			358			4.4
Managed care and other insurers		4,655			55.1			4,473			55.1
International (managed care and other insurers)		291			3.4			266			3.3
		8,469			100.2			8,195			101.0
Uninsured		693			8.2			739			9.1
Other		311			3.7			219			2.7
Revenues before provision for doubtful accounts		9,473			112.1			9,153			112.8
Provision for doubtful accounts		(1,023	)		(12.1	)		(1,041	)		(12.8	)
Revenues	$	8,450			100.0	%	$	8,112			100.0	%

	Six Months
	2013			Ratio			2012			Ratio
Medicare	$	4,114			24.4	%	$	4,302			26.0	%
Managed Medicare		1,647			9.8			1,479			9.0
Medicaid		697			4.1			810			4.9
Managed Medicaid		779			4.6			700			4.2
Managed care and other insurers		9,141			54.1			8,918			54.0
International (managed care and other insurers)		581			3.4			526			3.2
		16,959			100.4			16,735			101.3
Uninsured		1,092			6.5			1,181			7.2
Other		616			3.6			436			2.6
Revenues before provision for doubtful accounts		18,667			110.5			18,352			111.1
Provision for doubtful accounts		(1,777	)		(10.5	)		(1,835	)		(11.1	)
Revenues	$	16,890			100.0	%	$	16,517			100.0	%

The decline in Medicare revenues for the six months ended June 30, 2013 compared to the six months ended June 30, 2012 was primarily due to Medicare revenues for the six months ended June 30, 2012 being impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the six months ended June 30, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

XML

Segment and Geographic Information - Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA, Depreciation and Amortization and Assets (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2013	Mar. 31, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Segment Reporting Information [Line Items]
Revenues	$ 8,450		$ 8,112	$ 16,890	$ 16,517
Equity in earnings of affiliates	(12)		(9)	(20)	(20)
Adjusted segment EBITDA	1,689		1,569	3,257	3,392
Depreciation and amortization	425		420	849	837
Interest expense	462		448	934	890
Losses (gains) on sales of facilities	(4)		2	12	3
Loss on retirement of debt		(17)		17
Income before income taxes	806		699	1,445	1,662
National Group [Member]
Segment Reporting Information [Line Items]
Revenues	3,964		3,806	7,945	7,798
Equity in earnings of affiliates	(3)		(3)	(5)	(7)
Adjusted segment EBITDA	831		789	1,635	1,710
Depreciation and amortization	177		176	351	349
American Group [Member]
Segment Reporting Information [Line Items]
Revenues	4,065		3,966	8,099	8,051
Equity in earnings of affiliates	(7)		(7)	(13)	(14)
Adjusted segment EBITDA	916		841	1,744	1,814
Depreciation and amortization	202		202	404	405
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Revenues	421		340	846	668
Equity in earnings of affiliates	(2)		1	(2)	1
Adjusted segment EBITDA	(58)		(61)	(122)	(132)
Depreciation and amortization	$ 46		$ 42	$ 94	$ 83

XML

Contingencies and Legal Claim Costs - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	12 Months Ended				0 Months Ended
	Dec. 31, 2012 Y	Jun. 30, 2013 Hospital	Oct. 28, 2011 Cases	Dec. 31, 2003	Jan. 24, 2013 Pending Litigation [Member] Health Care Foundation of Greater Kansas City [Member]	Jul. 31, 2012 FLORIDA Hospital
Schedule Of Activities Related To Claims Filed [Line Items]
Number of owned and operated hospitals reviewed		95				8
Number of claims filed			3
Capital commitments in connection with purchase of hospitals				$ 450
Legal claim costs	175
Judgment award by the court					162
Period of agreed capital commitments	5 years
Number of year under court-supervisor accounting for expenditures following the purchase	10
Plaintiff attorneys fees award					$ 12

XML

Earnings Per Share - Schedule of Computations of Basic and Diluted Earnings Per Share (Detail) (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Earnings Per Share [Abstract]
Net income attributable to HCA Holdings, Inc.	$ 423	$ 391	$ 767	$ 931
Weighted average common shares outstanding	446,612	439,473	445,513	438,705
Effect of dilutive incremental shares	16,572	19,148	17,269	19,762
Shares used for diluted earnings per share	463,184	458,621	462,782	458,467
Basic earnings per share	$ 0.95	$ 0.89	$ 1.72	$ 2.12
Diluted earnings per share	$ 0.91	$ 0.85	$ 1.66	$ 2.03

XML

Interim Condensed Consolidated Financial Statements (Policies)

6 Months Ended

Jun. 30, 2013

Quarterly Financial Information Disclosure [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $65 million and $59 million for the quarters ended June 30, 2013 and 2012, respectively, and $131 million and $112 million for the six months ended June 30, 2013 and 2012, respectively. Operating results for the quarter and the six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,976			23.4	%	$	1,989			24.5	%
Managed Medicare		804			9.5			729			9.0
Medicaid		365			4.3			380			4.7
Managed Medicaid		378			4.5			358			4.4
Managed care and other insurers		4,655			55.1			4,473			55.1
International (managed care and other insurers)		291			3.4			266			3.3
		8,469			100.2			8,195			101.0
Uninsured		693			8.2			739			9.1
Other		311			3.7			219			2.7
Revenues before provision for doubtful accounts		9,473			112.1			9,153			112.8
Provision for doubtful accounts		(1,023	)		(12.1	)		(1,041	)		(12.8	)
Revenues	$	8,450			100.0	%	$	8,112			100.0	%

	Six Months
	2013			Ratio			2012			Ratio
Medicare	$	4,114			24.4	%	$	4,302			26.0	%
Managed Medicare		1,647			9.8			1,479			9.0
Medicaid		697			4.1			810			4.9
Managed Medicaid		779			4.6			700			4.2
Managed care and other insurers		9,141			54.1			8,918			54.0
International (managed care and other insurers)		581			3.4			526			3.2
		16,959			100.4			16,735			101.3
Uninsured		1,092			6.5			1,181			7.2
Other		616			3.6			436			2.6
Revenues before provision for doubtful accounts		18,667			110.5			18,352			111.1
Provision for doubtful accounts		(1,777	)		(10.5	)		(1,835	)		(11.1	)
Revenues	$	16,890			100.0	%	$	16,517			100.0	%

The decline in Medicare revenues for the six months ended June 30, 2013 compared to the six months ended June 30, 2012 was primarily due to Medicare revenues for the six months ended June 30, 2012 being impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the six months ended June 30, 2012.Certain prior year amounts have been reclassified to conform to the current year presentation.

XML

Contingencies and Legal Claim Costs

6 Months Ended

Jun. 30, 2013

Commitments And Contingencies Disclosure [Abstract]

Contingencies and Legal Claim Costs

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action has also been stayed pending developments in the shareholder class actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling. The accounting for HCA’s capital expenditures and charity and uncompensated care is ongoing and will likely not be concluded before the end of 2013. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters final judgment.

XML

Investments of Insurance Subsidiaries (Tables)

6 Months Ended

Jun. 30, 2013

Investments Debt And Equity Securities [Abstract]

Schedule of Investments

A summary of our insurance subsidiaries’ investments at June 30, 2013 and December 31, 2012 follows (dollars in millions):

	June 30, 2013
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	384	$	12	$	(2	)	$	394
Auction rate securities		47		—		(2	)		45
Asset-backed securities		12		—		—			12
Money market funds		17		—		—			17
		460		12		(4	)		468
Equity securities		2		1		—			3
	$	462	$	13	$	(4	)		471
Amounts classified as current assets									(66	)
Investment carrying value								$	405

	December 31, 2012
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—		$	418
Auction rate securities		74		—		(6	)		68
Asset-backed securities		14		—		—			14
Money market funds		67		—		—			67
		550		23		(6	)		567
Equity securities		2		1		—			3
	$	552	$	24	$	(6	)		570
Amounts classified as current assets									(55	)
Investment carrying value								$	515

Schedule of Maturities of Investments

Scheduled maturities of investments in debt securities at June 30, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	31	$	31
Due after one year through five years		174		180
Due after five years through ten years		103		106
Due after ten years		93		94
		401		411
Auction rate securities		47		45
Asset-backed securities		12		12
	$	460	$	468

XML

Interim Condensed Consolidated Financial Statements (Tables)

6 Months Ended

Jun. 30, 2013

Quarterly Financial Information Disclosure [Abstract]

Schedule of Revenues from Third Party Payers and Uninsured

Our revenues from third-party payers and the uninsured for the quarters and six months ended June 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,976			23.4	%	$	1,989			24.5	%
Managed Medicare		804			9.5			729			9.0
Medicaid		365			4.3			380			4.7
Managed Medicaid		378			4.5			358			4.4
Managed care and other insurers		4,655			55.1			4,473			55.1
International (managed care and other insurers)		291			3.4			266			3.3
		8,469			100.2			8,195			101.0
Uninsured		693			8.2			739			9.1
Other		311			3.7			219			2.7
Revenues before provision for doubtful accounts		9,473			112.1			9,153			112.8
Provision for doubtful accounts		(1,023	)		(12.1	)		(1,041	)		(12.8	)
Revenues	$	8,450			100.0	%	$	8,112			100.0	%

	Six Months
	2013			Ratio			2012			Ratio
Medicare	$	4,114			24.4	%	$	4,302			26.0	%
Managed Medicare		1,647			9.8			1,479			9.0
Medicaid		697			4.1			810			4.9
Managed Medicaid		779			4.6			700			4.2
Managed care and other insurers		9,141			54.1			8,918			54.0
International (managed care and other insurers)		581			3.4			526			3.2
		16,959			100.4			16,735			101.3
Uninsured		1,092			6.5			1,181			7.2
Other		616			3.6			436			2.6
Revenues before provision for doubtful accounts		18,667			110.5			18,352			111.1
Provision for doubtful accounts		(1,777	)		(10.5	)		(1,835	)		(11.1	)
Revenues	$	16,890			100.0	%	$	16,517			100.0	%

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2013	Jul. 31, 2013
Document Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Entity Registrant Name	HCA HOLDINGS, INC.
Entity Central Index Key	0000860730
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		447,200,900

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

Schedule of Computations of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the quarters and six months ended June 30, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	Quarter				Six Months
	2013		2012		2013		2012
Net income attributable to HCA Holdings, Inc.	$	423	$	391	$	767	$	931
Weighted average common shares outstanding		446,612		439,473		445,513		438,705
Effect of dilutive incremental shares		16,572		19,148		17,269		19,762
Shares used for diluted earnings per share		463,184		458,621		462,782		458,467
Earnings per share:
Basic earnings per share	$	0.95	$	0.89	$	1.72	$	2.12
Diluted earnings per share	$	0.91	$	0.85	$	1.66	$	2.03